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Campylobacter jejuni, a major enteric pathogen and a natural resident in the poultry 
gut, causes gastrointestinal illness followed by severe post-infection complications, 
including Guillain-Barré syndrome, reactive arthritis, myocarditis, and ulcerative 
colitis in humans. Risk assessment studies have projected a 30-fold reduction in human 
campylobacteriosis cases with only a 100-fold reduction in the number of C. jejuni 
colonizing the poultry gut. Current commercial poultry production practices involve 
use of antibiotic growth promoters (AGP); modulation of gut microbiota with AGPs 
for food safety and enhanced performance in poultry can be justified until acquisition 
of antibiotic resistance in zoonoses through inter-bacterial transfer of antibiotic 
resistance genes (ARGs) in a complex microbial community is considered. As an 
  
alternative, natural phenolics extracted from by-products of berry juice industry, with 
antimicrobial, anti-inflammatory, anticarcinogenic, antioxidant and vasodilatory 
activities, demonstrate promising prospects. In this study, we adopted mass-
spectrometry, microbiological, phylogenetic, and metagenomic approaches to evaluate 
bioactive phenolic extracts (BPE) from blueberry (Vaccinium corymbosum) and 
blackberry (Rubus fruticosus) pomaces as AGP alternative. We detected that major 
phenolics in BPE included, but were not limited to, apigenin, catechol, chlorogenic 
acid, cinnamic acid, coumarin, ellagic acid, eugenols, flavan, gallic acid, gingerol, 
glucosides, glucuronides, myricetin, phenols, quercetin, quinones, rhamnosides, 
stilbenol, tannins, triamcinolone, and xanthine. BPE reduced C. jejuni growth and 
motility in vitro, resulting in lower adherence and invasiveness to chicken fibroblast 
cells. Anti-inflammatory effects of BPE significantly reduced the expression of pro-
inflammatory cytokine genes in chick macrophage cell line ex vivo. Furthermore, BPE 
reduced the colonization of C. jejuni in broiler cecum by 1 to 5 logs while increasing 
broiler weight by 6% compared to 9.5% with commercial AGPs. Metagenomic analysis 
of broiler gut indicated that BPE caused an AGP-like pattern in bacterial communities 
with a comparative increase of Firmicutes and a concomitant reduction of Bacteroidetes 
in broiler ceca. AGP supplementation clearly caused phage induction and a richer 
resistome profile in the cecal microbiome compared to BPE. Functional 
characterization of cecal microbiomes revealed a significant variation in the abundance 
of genes involved in energy and carbohydrate metabolism. Our findings established a 
baseline upon which mechanisms of plant based antimicrobial performance-enhancers 
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Chapter 1: Literature Review 
Campylobacteriosis. Campylobacter is one of the major enteric pathogens and is the causative 
agent of major foodborne bacterial illnesses in the US. Campylobacteriosis, an infectious disease 
of the gastrointestinal tract, is caused by this pathogen. Diarrhea with presence of mucus and blood 
in stool, abdominal cramp, fever, nausea, vomiting and loss of appetite are the major identifying 
symptoms of the infection with Campylobacter. Campylobacter is responsible for 845,025 
infections, 8,463 hospitalizations and 76 deaths in the US annually (Scharff, 2012). According to 
the World Health Organization, approximately 5%-14% of all diarrhoea worldwide is thought to 
be caused by Campylobacter. In 2012, Foodborne Diseases Active Surveillance Network 
(FoodNet) identified 14.3 Campylobacteriosis cases for every 100,000 inhabitants of the twelve 
states of the US and this rate was 14% higher than the rates found in 2006-2008. This is regarded 
as the highest rate of Campylobacter infections in the century. More importantly, according to the 
Center for Disease Control and Prevention (CDC), for every laboratory confirmed 
Campylobacteriosis case, 30 more cases go unrecorded and/or unreported in the US. On an 
average, each laboratory confirmed Campylobacteriosis case result in an expanse of 1,846 US 
Dollars, which make up a total of more than 1.5 billion US Dollars average annual cost in the US 
(Scharff, 2012). As a result, Campylobacter is considered a serious threat to public health as well 
as national and global economy. 
 
Classification and ecology of Campylobacter. Campylobacter, a microaerophilic, spiral-shaped, 
Gram-negative bacterium, is a major cause of bacterial 
gastroenteritis worldwide. Campylobacter genus includes 
17 species and C. jejuni and C. coli are the most common 
isolates and involved in human gastrointestinal infection. 
Campylobacter generally reside in the intestinal mucosa of 
worm blooded animals. Once they are spilled or excreted 
from the gut of the host, Campylobacter encounter various 
hostile environmental factors, such as abnormalities in 
osmolarity, high concentration of atmospheric oxygen, high/low temperature, and insufficient 











host or adoption of stress-response mechanisms. One of the stress response in Campylobacter is 
conversion into Viable but Non-Culturable (VBNC) state where bacterial cells become coccoid 
instead of spiral shaped. Campylobacter can also develop mechanisms for survival in unfavorable 
environment by expressing SoxRS and OxyR proteins against oxidative stress, BetAB, GbsAB, 
OtsAB and ProP proteins as osmoprotectants or cold shock protein CspA (Murphy et al. 2006). 
Optimum growth temperature for Campylobacter is around 42ºC, as a result poultry can 
serve as a major host of this pathogen due to its relevant body temperature. Elevated temperature 
help Campylobacter for proper gene expression, regulation of energy/nutrient metabolism and 
further proliferation. As a result, transmission from Campylobacter colonized chicks to humans is 
an important possible risk factor and possibility of which often increases as the number of 
interaction between them increases. Broiler flocks can be colonized by Campylobacter which 
depends on the age of the birds. The shedding of this pathogen starts about 2-3 weeks after hatch 
and over time virtually all the birds become contaminated. It has been found that the spread of the 
infection from a single bird to a flock size of 30,000 birds can happen within 3 days. Once 
colonized, bacterial load can reach upto 107 CFU per g of cecum content (Stern et al., 1995). 
Campylobacter can colonize the whole gut but the colonization of this bacteria is mostly favorable 
in cecum and colon of poultry though they are also found in the crop and the lower intestine. 
Intermittent colonization of duodenum, jejunum, ileum, spleen and liver has also been reported.  
Genotypic similarity has been found among Campylobacter isolates from human and 
poultry where majority of the birds were found to be colonized with Campylobacter (Nadeau et 
al., 2002). Others report that the colonization of Campylobacter is host-specific which limit the 
occurrence of common serotype among humans, poultry or other animals. There are several factors 
that are important in transmission of Campylobacter from bird to bird, the most important may be 
physical proximity. However, in some cases, flocks residing at close proximity was also found free 
from Campylobacter contamination which indicated the involvement of factors other than physical 
proximity in the transmission of Campylobacter from bird to bird. Berndtson et al., (1996) reported 
that Campylobacter was not able to transmit from one pen to another if the pens were divided with 
a physical barrier, which raise the question on the possibility of Campylobacter transmission 
through air. The capability of Campylobacter to enter the eggshell under certain conditions has 
been reported which support the vertical transmission of this pathogen, but there are still valid 





reservoir or vector for Campylobacter transmission to Campylobacter-free flocks. After 
establishment of initial colonization, even with a small number of viable or VBNC Campylobacter 
cells in an individual bird, horizontal transmission causes the entire flock to be infected with this 
pathogen at a very short period of time. Initial colonization of specific subtype of Campylobacter 
differ from the predominant subtypes prevalent at the time of slaughter which indicates further 
transmission of new subtypes from the environment on the later stage of poultry lifecycle (Bull et 
al., 2006). The reason behind the migration from one dominant subtype or species to another is 
still unknown, but may result from seasonal variations, environmental alterations or later subtype 
being genetically more favorable to replace the older subtype. 
Campylobacter can also reside in the intestinal tract of production animals, like cattle, pig, 
sheep and goats. Like poultry, C. jejuni is the major species recovered in the cattle (Bae et al., 
2005; Harvey et al., 2005; Inglis et al., 2004) although it has been reported that the prevalence of 
C. coli was nearly as high as C. jejuni (20% C. coli, 23.8% C. jejuni) in operations that rear calves 
(Bae et al., 2005). The presence of Campylobacter in cattle rumen is not supported by many 
investigators, who suggest their presence is more likely due to recent ingestion rather that active 
infection with the bacteria. Other organs of the cattle, such as, gallbladder, bile and mucosal tissue 
have been reported to harbor Campylobacter. Unlike poultry, C. coli is more prevalent in swine 
and in some studies, C. coli was isolated in 99% cases. Jensen et al., (2013) found severe 
fluctuations in the number of C. jejuni or C. coli colonized in the intestine of swine though C. coli 
was always more prevalent than C. jejuni. Infection of various hosts with various species implies 
the requirement for certain condition for the survivability of specific species of Campylobacter. 
The use of synthetic antibiotics also alter the composition of Campylobacter species. Swine grown 
without antibiotic was shown to contain 50% more C. coli compared to the farms where antibiotic 
were not used. C. jejuni was found to be more resistant to environmental stresses such as 
chlorinated water treatment or chilling. Thereby these inhibiting stresses might reduce the level of 
C. coli than C. jejuni. 
Wild birds and animals can also be colonized with Campylobacter at a catastrophic level. 
Campylobacter serotypes from the wildlife have been shown to be similar to the human clinical 
isolates. As a consequence, wild birds, pests, flies, and other small wildlife animals have been 
considered as possible vectors for Campylobacter transmission to farm animals (Hald et al., 2004; 





documented, several outbreaks of Campylobacteriosis associated with raw vegetables indicate the 
survival ability and transmission of Campylobacter through produce (Harris et al. 2003; Jacobs-
Rietsma 2000; Mandrell and Brandl 2004). However, the pathogen showed susceptibility to air-
drying on abiotic surfaces (Kusumaningrum et al., 2003), UVB exposure (Obiri-Danso et al., 
2001), hydrostatic pressure (Solomon and Hoover, 2004), and acidic pH (Waterman and Small 
1998). It was found that Campylobacter could not survive or converted to VBNC state in absence 
of sufficient water activity on produce, hence contamination of produces with animal feces might 
be the reason of Campylobacter on produce surface. Campylobacter was also isolated from both 
free flowing environmental streams as well as stagnant water (Hörman et al., 2004), so water may 
also be linked to the transmission of Campylobacter in wild and domesticated animals.  
 
Campylobacter in food and environment. Products including raw and undercooked poultry meat, 
unpasteurized milk and some other food products were found to harbor Campylobacter. Due to 
cross contamination during evisceration process, Campylobacter primarily transmits to the skin of 
infected birds from contaminated equipment, gut and cecum content at the poultry processing 
plants (Berrang et al., 2001). Campylobacter spp. occupies a liquid film on the carcass and are 
entrapped in the channels and crevices of skin (Chantarapanont et al., 2003) which provides a 
favorable microenvironment for survival and growth. This suitable microenvironment foster the 
growth and survival of Campylobacter (Chantarapanont et al., 2003) and Campylobacter spp. are 
capable to persist in the carcass even under freezing temperature or refrigerated storage condition. 
Contamination in muscle tissue has also been reported during storage in retail shops. It was found 
that almost half of all packaged chicken legs were contaminated on the skin alone, less than 1% of 
samples were positive within the muscle alone in retailers (Scherer et al., 2006). The prevalence 
of Campylobacter in meat samples were 87.5%, 71.43% and 33.33% in farmers markets, organic 
and retail supermarkets in Maryland and the DC metropolitan area, respectively (Salaheen et al., 
unpublished data). Scheinberg et al. (2013) reported that 90%, 28% and 52% of chicken meat 
samples collected from farmers market, organic and non-organic sources, respectively, were 
positive for Campylobacter in Pennsylvania. The prevalence of Campylobacter in the poultry 
meats from organic and conventional retail supermarkets ranges from 43% to 89% in the US 
(Smith et al. 1999; Zhao et al. 2001; Cui et al. 2005; Price et al. 2005; Luangtongkum et al. 2006; 





organic and conventional retail meats, respectively in Maryland. At similar period, Price et al. 
(2007) reported 67 to 97% contamination rate in Maryland. So, it is evident that post-harvest 
poultry products are highly contaminated with Campylobacter. 
 
Infection, complications and post infection sequelae. The infection and virulence strategies 
exploited by Campylobacter is still far from being elucidated. Genomics, proteomics, and 
metabolomics tactics show high inter- and intra-strain variation in Campylobacter. This diverse 
nature facilitates adaptive mechanism by which Campylobacter survive in various environmental 
conditions and interacts with the mucus layer of the gut. Studies suggest that Campylobacter starts 
the infection by actively penetrating the intestinal mucosa layer followed by discharging toxin 
(cytolethal distending toxin, cdt A, B and C) or proteins (Campylobacter invasion antihgen, cia) 
via flagellar apparatus which serve as Type III secretion system in this bacteria. Being modulated 
by the proteins, epithelial cells engulf Campylobacter which disrupts the integrity of the epithelial 
lining. Pro-inflammatory cytokines, chemokines and effector molecules of the innate immunity 
are highly induced when Campylobacter antigens are presented by the antigen presenting cells. 
Complications related to Campylobacter infections arise at this stage which include pancreatitis, 
cholecystitis, peritonitis, and substantial gastrointestinal hemorrhage. Transient bacteremia arises 
occasionally in immunocompetent patients. Though, serious systemic illness caused by 
Campylobacter can lead to sepsis and death, which is rarely reported. Rather than food poisoning 
and local Campylobacter enteritis, post infection sequelae of Campylobacteriosis, such as 
Guillain-Barre´ syndrome, rewactive arthritis, cardiac problem, and uncreative colitis are more 
important in terms of health hazard and economic burden. 
The most important post-Campylobacteriosis complication is the Guillain-Barre´ 
syndrome (GBS). GBS is considered as an acute demyelinating disease of the peripheral nervous 
system that result in < 1 patient per 1000 cases affecting 1-2 persons per 100,000 people annually 
in the US. It has been speculated that the risk of developing GBS is amplified after infection with 
certain Campylobacter serotypes, for example, in the US, Penner type O:19 is commonly linked 
to GBS development. 
Reactive arthritis associated with Campylobacter infection and prevalence varies 





and genetics and ages of exposed patients (Pope et al., 2007). Five percent of Campylobacter-
associated reactive arthritis were found to be chronic or revert with musculoskeletal symptoms. 
Incidences of C. jejuni-associated myocarditis and myopericarditis have been reported, all 
of which involved immunocompetent hosts (Uzoigwe, 2005). Typical clinical symptoms involved 
transitory acute pain in chest, with concomitant electrocardiogram variations and increased 
secretion of cardiac enzymes, in association with antecedent or coincident enteritis.  
Ulcerative colitis (UC) is a chronic inflammatory condition of the large intestine of human 
beings. It is characterized by the presence of bloody diarrhea and severe abdominal cramp and 
abnormal immune functions, defect in intestinal epithelial cell barrier function, and gut microbiota 
(Campieri and Gionchetti 2001, Sasaki et al 2012). UC is also considered to be a pre-condition in 
colorectal cancer (CC) (Rhodes and Campbell 2002). Campylobacter spp., and Entero 
Haemorrhagic E. coli (EHEC) were predominant in tissue sample collected from patients with UC, 
but not in tissues from healthy individuals (Gradel et al 2009; Ternhag et al 2008).   
 
Sub-therapeutic use of antibiotics in farm animal production and its consequences. Though 
antibiotics have served significantly to make foods safer, they present certain limitations which 
have led many people to rethink on their application in animal feed. There are many direct negative 
impacts as well as indirect effects of these antimicrobials towards life in general. Since the mid-
20th century, when the application of antibiotics against bacterial and fungal diseases was first 
introduced, it has been considered as the single most important medical event in human history. It 
has reduced morbidity and mortality in human and animal to a dramatic level. Since then, the use 
of antibiotics accounts for several million tons worldwide both for medication and in farm animal 
production (Andersson and Hughes, 2010). The intensive use of antibiotics caused a huge 
influence in the frequency of resistance among bacterial pathogens including Campylobacter. 
Enhanced rate of microbial resistance could be reduced or minimized if we could use the 
antibiotics effectively and properly in treatment of human diseases and farm animals. As the 
antibiotic resistant microorganisms are more virulent and aggressive in respect to disease 
occurrence, this may increase the risk of complicated situations and fatality, escalate the economic 
burden on public health and may eventually introduce a dreadful post-antibiotic era.  
Since the 1950s, large amounts of antibiotics have been used in agricultural animal 





and ability to enhance feed conversion efficiency. Flavophospholipol and virginiamycin are 
generally used in the US for poultry production (Peter and John, 2004). Β-lactam antibiotics (e.g., 
penicillin, lincosamide), macrolids (e.g., erythromycin, tetracycline) are used mainly in pigs (Peter 
H. and John H., 2004). Some other antimicrobials, such as arsenical compounds, bacitracin, 
flavophospholipol, pleuromutilins, quinoxalines and virginiamycin, are also used in pig 
production. In the cattle industry flavophospholipol, monensin, and virginiamycin are generally 
used as growth promoter because these compounds play important roles in muscle formation and 
increase milk productivity (Peter H. and John H., 2004). Some antibiotic candidates approved by 
FDA for pre-harvest use in cattle, swine and poultry are listed in Table 1.1. 
Pre-harvest use of antibiotic is common in farm animal production but instead of specific 
targeted pathogens, antibiotics are used for diverse groups of pathogens. As a result, broad-
spectrum antibiotics are used in pre-harvest level. Recent studies suggest that some antibiotic 
treatment can disrupt the dynamics of gut flora and therefore impair animal health and 
productivity, and even food safety (Crosswell et al., 2009). Aarestrup et al., (1998) carried out an 
intensive research on the manifestation of acquired resistance to antimicrobials which were used 
for animal growth promotion among bacteria that are generally isolated from poultry, cattle and 
swine in Denmark. They used three groups of bacteria, such as, indicator bacteria (E. coli, 
Enterococcus faecalis, Enterococcus faecium), 2) zoonotic bacteria (Campylobacter, Salmonella, 
Yersinia enterocolitica), and 3) animal pathogens (E. coli, Staphylococcus aureus, coagulase-
negative staphylococci (CNS), Staphylococcus hyicus, Actinobacillus pleuropneumoniae). 
Antimicrobials that were generally used as growth promoters in Denmark and some structurally 
related therapeutic agents were included in the study. Those included: avilamycin, avoparcin 
(vancomycin), bacitracin, carbadox, flavomycin, monensin, olaquindox, salinomycin, spiramycin 
(erythromycin, lincomycin), tylosin, and virginiamycin (pristinamycin). The research group 
reported acquired resistance to all of the tested antibiotics. A more frequent incidence of resistance 
were found against avilamycin, avoparcin, bacitracin, flavomycin, spiramycin, tylosin and 
virginiamycin, whereas resistance to carbadox, monensin, olaquindox and salinomycin was less 
frequent. For these consequences, the European Union banned the use of antibiotics for farm 
animal production as growth promoters (avoparcin in 1997 and bacitracin, spiramycin, tylosin and 
virginiamycin in 1999). In the US, certain use of cephalosporin in production animals were 





footstep of the EU to ban non-therapeutic use of antibiotics in food animal production. As a result, 
alternative growth promoters and antimicrobial agents are required more than ever. 
 
Alternative approaches for prophylaxis and animal growth promotion. To combat the current 
situation regarding bacterial contamination, antibiotic resistance and animal growth promotion, 
natural phenolic compounds can play important roles to reduce pre-harvest colonization of 
zoonotic bacterial pathogen, specifically Campylobacter from animal (poultry) gut. Polyphenols, 
a widely available groups of compounds naturally occurring in plants, are an integral part of the 
human and animal diet. Chemically, polyphenols are characterized by hydroxylated phenyl 
moieties. In fruits and vegetables, they are typically occurred in their glycosylated forms, though 
alterations such as polymerization or methylation are frequently observed. Polyphenols have 
gained interest in the last decades for having possible health-promoting effects such as 
antimicrobial,  anti-inflammatory, anti-estrogenic, cardio-protective, chemo-protective and neuro-
protective properties (Steinberg et al., 2003; Selma et al., 2009) as well as antioxidant and pro-
oxidant activities both in vitro and in animal models (Halliwell et al., 2007).  
Polyphenols are prevalent in many fruits and vegetables. For example, they are the main 
components of pomegranate. Clinical research reported that it takes up to 56 hours for the 
phenolics, mostly punicalagins, to leave the colon, because they are absorbed very slow and not 
completely (Seeram et al., 2006). During this time, it is proved that pomegranate tannins inhibit a 
large number of pathogens in that section of the gut without affecting most beneficial bacteria 
(Bialonska et al., 2009). Pomegranate constituents seem to disturb both Gram-positive and Gram-
negative intestinal pathogenic bacteria. According to previously published reports (Bialonska et 
al., 2009), ellagic acid inhibited the growth Clostridium clostridioforme, C. perfringens, and C. 
ramosum. Ellagic acid together with punicalagins was effective against the growth of Bacteroids 
fragilis and S. aureus. The effect of pomegranate polyphenols on bifidobacteria was species-
specific. The number of Bifidobacterium. breve and B. infantis increases in the presence of the 
pomegranate ellagitannins which indicated that pomegranate products may help regulate 
pathogens without adverse effects on beneficial bacteria (Howell et al., 2013).  
In red raspberries the main phenolic compounds are ellagitannins, followed by flavonoid 
and anthocyanins. Antimicrobial activity of tannins against microorganisms is well documented. 





showed similar selective bactericidal effects on both Gram-positive and Gram-negative bacteria. 
Raspberries are effective inhibitors of Staphylococcus and Salmonella Typhimurium (Puupponen-
Pimia et al., 2005). Other types of bacteria being affected by the phenolic compounds in raspberries 
include E. coli (Nohynek et al., 2006) and Salmonella enterica (Puupponen-Pimia et al. 2001). The 
growth of Lactobacillus was not inhibited by any of the raspberry extracts at low concentrations. 
However, in high concentrations, the growth of the probiotic was clearly disrupted (Puupponen-
Pimia et al. 2005). 
The composition of the cranberry polyphenols has been widely documented as a 
combination of flavonoids and phenolic acids like catechin, myricetin, and benzoic acid, the latter 
of which is the most prominent one in a freshly squeezed sample of juice (Chen et al., 2001). 
Cranberries are also rich in a phenolic compound called proanthocyanidins. Proanthocyanidins 
have been cataloged as the ones responsible for the cranberry’s great ability to disrupt bacterial 
adherence to cultured human cells (O’May and Tufenkji, 2011).  Howell et al., (2005), concluded 
that the proanthocyanidins in cranberry juice can prevent the adhesion of E. coli to the urinary tract 
thus preventing urinary tract infections. Furthermore, biofilm formation in uroepithelial cells can 
also be reduced by ingesting cranberry juice (Reid et al., 2001). The antimicrobial effects of 
cranberry juice have been recorded several times. Historically, women have been told to drink the 
juice in order to prevent and even cure urinary tract infections. In the early 1990s, researchers 
found that the monosaccharide fructose present in cranberry and blueberry juices competitively 
inhibited the adsorption of pathogenic E. coli to urinary tract epithelial cells, acting as an analogue 
for mannose (Zafriri et al, 1989). Different research studies have proven the antimicrobial 
properties of cranberries against both Gram-positive and Gram-negative bacteria. Cranberry 
extract has been demonstrated being effective towards Bacillus cereus, Clostridium perfringens, 
and Staphylococcus epidermis; lyophilized cranberry had a bacterocidic impact on Salmonella 
Typhymurium, Staphylococcus aureus and Listeria monocytogenes (Puupponen-Pimia et al. 
2005). Also, coumaric acid, another phenolic acid present in cranberry juice, has confirmed 
efficacy on Lactobacillus plantarum (Nualkaekul and Charalampopoulos, 2011). In a separate 
study, proanthocyanidins were proved to be effective in blocking part of the motile system of 
Pseudomonas aeruginosa (O’May and Tufenkji, 2011). This study showed that the growth of P. 





bacteria was disrupted, which indicated a disruption in swarming motility in the presence of 
cranberry phenolics. 
Phytochemical additives from plant sources are potent dietary supplement for animals 
including poultry. Some of these compounds stimulate appetite (e.g. menthol), provide antioxidant 
protection (e.g. anthocyanin, cinnamaldehyde) or reduce harmful microbial growth. Plant essential 
oils induce endogenous digestive enzymes in the intestinal tract. Oregano essential oils were 
shown to act as growth promoter in poultry though the exact mechanism could not be explained. 
However, carvacrol from oregano extract shows antimicrobial effect, its essential oils can 
modulate the gut microflora and reduce bacterial load by suppressing the proliferation of bacteria. 
Phenolic extracts from plant origin stimulate gastric juice secretion which improves digestive 
power in animals. Some polyphenols are also purported to function by raising blood circulation 
rate, which leads to faster detoxification in animal body that were generated from metabolic 
pathways. Flavonoids are important plant polyphenols which maintain the shape of small blood 
vessels and connective tissue. 
 
Natural bioactive extracts from berry pomace. Bioactive phytochemicals from berries, especially 
blackberry (Rubus fruticosus) and blueberry (Vaccinium corymbosum) pomace as feed or water 
supplement to reduce pre-harvest level of Campylobacter colonization in poultry, might be a 
feasible alternative because extraction of bioactive phytochemicals from fruit juice is too 
expensive for large scale application in the production animals specifically poultry. Pomaces, the 
by-products of fruit juice industry, are the solid or semisolid remains of fruits after separating out 
the juice or oily portion. It consists of skins, stem, seeds and small amount of pulp of the fruit. 
Berry juice and fruit processing industries produce a significant amount of pomaces. Pomace 
generally accounts for as much as 20-30% of the weight of the whole fruit. According to National 
Agricultural Statistics Service (2009), a significant amount of pomaces are produced in the US 
annually which result in disposal problem as they cannot be used as animal feed for having low 
protein content and acidic pH. As a result, an alternate use of these byproducts will be highly 
appreciated. Cultivation of berries is season dependent but they are stored by the juice factories to 
have a year round supply of fruits confirming a year round supply of pomaces. So these byproducts 
can be used to extract polyphenolic compounds, which have been demonstrated to have numerous 





anti-allergic, anti-hypertensive, anti-arthritic and anti-microbial properties (Boivin et al., 2007).  
They also inhibit lipid peroxidation, act as free radical scavengers and metal ion chelators. 
Moreover, these phenolics are concentrated in the outer layers of fruit (e.g. skin) as their 
biosynthesis is dependent on UV-light (sunlight). So, cheap extraction of the phenolics from berry 
pomace would provide a solution to both the fruit industry and the poultry industry.  
 
Composition of berry pomace. The major bioactive components present in pomaces (a list of 
phytochemicals present in pomaces and essential oils are summarized in Table 1.2) are 
polyphenols, phytosterols, tocopherols (mostly as α- tocopherol), fibre, protein and biotic 
(Puupponen- Pimiä et al., 2001; Puupponen- Pimiä et al., 2005; Puupponen- Pimiä et al., 2008). 
There are different classes of polyphenols and each class has unique characteristics which separate 
one from other. Phenolic compounds are one of the most diverse secondary metabolites found 
berry pomace. Major components of the polyphenols are anthocyanins (cyanidine-3-galactoside 
and cyanidine-3-glucoside), procyanidins and hydroxycinnamic (α-Cyano-4-hydroxycinnamic 
acid). Procyanidins, present in the pomace, is a class of polymeric polyphenolics and it contains 
catechin or epicatechin at polymerized form (Djilas et al., 2009). Cyanidin-3-glucoside and 
cyanidin-3-galactoside are particular types of anthocyanin pigments found in many berries 
including blackberry and blueberry (Sasaki et al., 2007). The highest concentrations of cyanidin 
are found in the skin and seed of these fruits because their biosynthesis are stimulated by sunlight 
(ultraviolet light), so higher concentrations are found in the most outer layer (skin) of the fruit. 
Different linkages between catechin and epicatechin units are found in procyanidins, the most 
common being β-type linkages. Oligomeric procyanidins demonstrated greater antimicrobial 
activity even at lower concentrations than catechin and epicatechin though the degree of 
polymerization on antimicrobial activity still remains unclear. 
 
Antibacterial properties of berry phenolics. Bioactive compounds extracted from pomaces 
(especially berry fruits) have been shown to inhibit different foodborne pathogens as well as food-
spoiling microorganisms. According to Puupponen-Pimiä et al. (2001), berry extracts inhibited the 
growth of Salmonella, Escherichia, Staphylococcus but not Lactobacillus and Listeria species. 
Cavanagh et al. (2003) showed inhibitory effect of several berry extracts on the growth of wide 





blueberry extract has negative impact on the growth of Salmonella, Escherichia, Campylobacter 
and Listeria whereas stimulates the growth of probiotic Lactobacillus. In other study, human 
intestinal bacteria such as Bacteroids fragilis, Clostridium perfringens, E. coli and Salmonella 
Typhimurium were found to be inhibited by tannins while Bifidobacterium infantis and 
Lactobacillus acidophilus were unaffected by this group of phenolics (Chung et al., 1998). 
Inhibitory effect of phenolic compounds such as flavonoids, against Multi-Drug Resistant (MDR) 
bacteria and methicillin-resistant Staphylococcus aureus has been documented (Belofsky et al., 
2004). Roccaro et al., (2004) found that catechin can increase tetracyclin activity against 
tetracyclin-resistant staphylococcal isolates. Pomace essential oils also have been documented to 
have effect against various microorganisms. Muthiyan et al. (2012) found bioactive essential oils 
can be used as anti-Staphylococcal agent. Essential oils and terpineol were also found to extend 
the shelf life of milk to more than 56 days when stored at 4˚C. According to Kim et al. (1995), 
carvacrol, citral and geraniol had strong activity against Salmonella Typhimurim and its rifampicin 
resistant mutant in vitro but nerolidol, limonene or β-ionone had no effect on similar kind of 
bacteria suggesting different compounds have different target microorganism as well as different 
mechanism of action. 
Several mechanism of action of berry pomace extracts have been proposed which include 
cytoplasmic membrane destabilization, permeabilisation of plasma membrane, extracellular 
microbial enzyme inactivation, direct effect on microbial metabolism, deprivation of substrates 
mandatory for microbial growth (Puupponen- Pimiä et al., 2004). These extracts may also play 
role in alteration of host epithelial cell-pathogenic bacteria interactions which is a prerequisite for 
colonization and infection of many pathogenic bacteria. Clifford et al. (2004) documented that 
dietary phenolics are poorly absorbed in the small intestine and 90-95% accumulate in colon which 
possess the capability to alter host cell-bacterial interactions. Cytoplasmic membrane, a 
semipermeable membrane in microbes is a phospholipid bilayer which contain embedded proteins 
(Millard, 2002) that regulate the movement of solutes and different metabolites in and out of the 
cell. Phenolics penetrate cytoplasmic membrane and interact with cellular proteins. Concentration 
dependent mechanism is also proposed from several researches. Cellular enzyme activity is 
affected at lower concentration of phenolics whereas higher concentration may cause protein 
denaturation. Walsh et al. (2003) reported membrane damage as a mode of action of phenolic 





acid synthesis. Carvacrol acts on cytoplasmic membrane, acts as a proton exchanger and hampers 
the pH gradient across the cytoplasmic membrane, disrupt proton motive force and deplete 
intracellular ATP resulting in cellular death (Ultee et al., 2002). Hydroxycinnamic acids, due to 
having less polar side chain, can penetrate inside the cell very easily (Campos et al., 2003). Tannins 
inhibit oxidative phosphorylation by disrupting extracellular microbial enzymes or eliminating 
substrates for enzymatic reaction which affect microbial metabolism (Scalbert 1991). Tannins can 
also cause complexation of metal ions required for bacterial growth. The effect of phenolics on 
MDR bacteria is due to its ability to impair efflux pumps, which bacteria use to get rid of antibiotics 
and that cause an increase in the drug retention time inside bacterial cells. Yoda et al. (2004) 
concluded that green tea polyphenol, EGCG directly bind to cell wall components and causes 
inhibition whereas Zhao et al. (2001) showed EGCG and β-lactams attach to the same site which 
is peptidoglycan of bacterial cell wall and confer synergistic relationship to β-lactams. EGCG have 
also been shown to interfere with the transfer of conjugative R plasmid in E. coli which is 
responsible for the conjugative plasmid mediated antibiotic resistance in bacteria. Most of the 
acidic components of pomace extracts show similar mode of action, the pKa of most phenolic 
acids ranges between pH 3 and pH 5, due to the higher pH of cytoplasmic membrane compared to 
surrounding medium, these compounds dissociates and release proton which acidifies cytoplasm 
(Cotter and Hill 2003). Anionic portion of these acidic compounds which cannot escape 
accumulate within bacterial cell and impair metabolic function such as increase osmotic pressure 
which causes incompatibility to bacterial cell. There are other hypothesized modes of actions 
which need to be evaluated. 
 
Anti-inflammatory properties of berry phenolics on host and potential as alternative growth 
promoter in production animals. In vitro and in vivo studies in animal model have found 
polyphenolic compounds to alter the animal immunity and mainly serve by exerting anti-
inflammatory effect. Polyphenols can modify and/or alter various biochemical pathways related 
to signal transduction in eukaryotic cells which elicit their beneficial properties. These alterations 
include, modulation of pro-inflammatory cytokine gene expression such as interleukin-6, 
interleukin-8, cyclooxygenase, nitric oxide synthases, lipoxygenase, and several non-specific 
cytokines. These modulations are generally carried out by several alterations in mitogen-activated 





(2001) reported that polyphenols, such as epicatechin gallate, epigallocatechin and 
epigallocatechin gallate decreased the production of pro-inflammatory cytokine interleukin-1β and 
enhanced the production of anti-inflammatory cytokine interleukin-10, but had no effect on the 
production of interleukin-6 or tumor necrosis factor. Deng et al., (2010) carried out a study on the 
immunomodulatory potential of polyphenolics in piglet model. Their study concluded that 
polyphenols stimulated the activation and proliferation of T lymphocytes. The ratio of 
CD4+/CD8+ cells was also raised, which indicated a recovering mechanism against oxidative 
stress mediated immune damages. The attenuation of pro-inflammatory cytokine interleukin-1 
caused by oxidative stress was observed, and the amount of serum interferon-γ was depleted by 
polyphenolic supplemented feed. However, the serum concentrations of interleukin-4, a prominent 
anti-inflammatory cytokine, were significantly enhanced suggesting an immune shift from Th1 to 
Th2. A more recent study showed that phenolic extracts reduced the morbidity and inflammation 
induced by Avian Pathogenic E. coli (APEC) (Zhong et al., 2014). APEC causes colibacillosis 
which results in inflammation in multiple organs of chickens, and results in serious economic loss 
to the poultry industry. Quantitative real-time polymerase chain reaction (qPCR) and enzyme-
linked immunosorbent assay (ELISA) results showed that the phenolic extracts reversed the 
induction of the Toll-like receptor (TLR) 2, 4, and 5, genes and down-regulated nuclear factor-
kappa B signal transduction pathway activation, and inhibited the production of proinflammatory 
cytokines.  
Anti-inflammatory properties can be attributed with growth promotion in animals, 
especially in poultry. From the last five decades, sub-therapeutic concentrations of antibiotics have 
been used to grow production animals for growth promotion. Several mechanisms have been 
proposed, none of which is beyond controversy. In earlier hypotheses, the growth promoting 
effects of antibiotic growth promoters (AGP) were linked with only their antimicrobial properties 
which seems unlikely because sub therapeutic concentrations of AGPs possess limited growth 
inhibitive effect on microbes, and AGPs are still in effect despite the wide-spread development of 
resistance among pathogens (Cox and Popken, 2010). Furthermore, down regulation of intestinal 
mucosal immune responses was observed in a rodent model after sub-therapeutic use of 
tetracycline (Costa et al., 2011). As a result, anti-inflammatory properties of AGPs are more linked 
to animal growth promotion. Production animals can grow to their complete hereditary potential 





muscle catabolism and as a result Metabolic Inflammation (MI), i.e., local intestinal inflammation, 
is more important for production animals. Non-symptomatic infections and MI in production 
animals can be drastic which lead to reduced weight gain. Supplementation of anti-inflammatory 
compounds in feed may act as a remedy in such a situation and logically, polyphenol rich berry 
pomace extracts possess high potential to be an alternative to AGPs. 
 
Bioavailability of berry phenolics in host gut through gut microbial metabolism. The animal colon 
and gut serves as reservoir for an extremely compound microbial ecosystem, at concentrations of 
>103 microbes per gram of gut content, while the microbiome surpasses the human genome by 
100-fold, in terms of genetic diversity (Donohoe et al., 2011). The composition and diversity of 
gut microbiota diverges greatly from species to species, and even within species; so the 
composition of gut microflora is unique to an individual host and generally modulated by farming 
practices, diet, environmental conditions, healthy or diseased status, genotype, and so on 
(Turnbaugh  et al., 2008; Zoetendal et al., 2006).  
Depending on the degree of polymerization and the glycosylation pattern, a significant 
portion of dietary polyphenols can remain in the colon. These polyphenols are exposed to the 
colonic microbial community where microbial co-metabolism of polyphenols are carried out with 
a common pattern in which the tremendously varied collection of natural polyphenols are funneled 
to a relatively smaller group of metabolites. The microbial community of the gut possess various 
mechanisms to carry out O- and C-deglycosilation, amide and ester hydrolysis, and 
deglucuronidation of large flavonoids and also fermentation of the flavonoid structure. There are 
ample examples for the bioconversion of active nutritional composites into metabolites of higher 
bioavailability. For example, isoflavones from soy or hop prenyl-flavonoids are modulated by 
colonic microbial population for the pseudoestrogenic activity (Possemiers et al., 2006; Rowland 
et al, 1999). In vivo study on rat model with red wine powder detected microbial metabolites 
excretion through urine. The bioactive metabolites included hydroxybenzoic, hippuric, vanillic, 
phenylacetic, p-coumaric, phenylpropionic, caffeic, ferulic acids and catechins, though a majority 
of the above metabolites were absent in the wine powder that was used for feed supplementation 
in rats (Gonthier et al., 2003). Aura et al., (2005) showed that deglycosylation and breakdown of 
the anthocyanidin (a major plant phenolic) heterocycle were the major part of microbial 





with 5% fecal inoculum. Later studies found that inoculums from human and animals 
deglycosylated and hydrolyzed anthocyanins into a wide array of metabolites including 4-
hydroxybenzoic acid, syringic acid, vanillic acid, protocatechuic acid, and phloroglucinol 
aldehyde, where initial anthocyanins were completely disappeared from the in vitro system 
(Keppler et al., 2005; Fleschhut et al., 2006). These phenolic acids were derived from the β ring 
of the respective anthocyanidins, while α rings were broken down to aldehyde derivatives (Morand 
et al., 2004). In addition to the deglycosylation by microbial enzymes, the microflora are capable 
of mild transformation such as dihydroxylation, demethylation, and catabolism of polyphenols into 
simpler derivatives (Cermak et al., 2006). Specialists suggest that these derivatives, rather than 
their original precursors, may be responsible for the beneficial effects of polyphenols, since these 
derivatives are more easily absorbed and resilient to additional metabolism. 
So far, a very limited number of bacterial species have been identified in the laboratory to 
be capable of metabolizing polyphenols. The majority of the bacteria belong to the Clostridia 
group, lactic acid bacteria especially Lactobacillus, Bifidobacterium and Enterococcus spp. The 
enzymes of Lactobacillus plantarum involved in polyphenol metabolism include benzyl alcohol 
dehydrogenase, reductase, decarboxylase, tanase, β-glucosidase, phenolic acid decarboxylase and 
esterase (Rodríguez et al. 2009). Probiotic fermentation of phenolic extracts with Lactobacillus 
helveticus was used to mobilize phenolics and improve biological functionality by maintaining a 
constant phytochemical profile and as a result α-glucosidase inhibitory activity and Helicobacter 
pylori inhibitory potentials were increased (Ankolekar, 2013). Glycosylated flavanone, hesperidin 
derived from microbial metabolism of polyohenols showed antibacterial activity against 
Aeromonas hydrophila; a study on murin model revealed that hesperidin inhibited bacterial 
colonization and significantly increased anti-LPS IgM levels and reduced anti-LPS and anti-ECP 
IgA levels (Abuelsaad et al., 2013). Hidalgo et al., (2012) reported growth stimulation in 
Bifidobacterium, Lactobacillus and Enterococcus spp in presence of anthocyanin while forming 
gallic, syringic and p-coumaric acids. These findings indicate that polyphenols and their bioactive 
metabolites exert a positive modulation of the colonic microbial population.  
 
Synergistic relationship between traditional antibiotics to natural phenolics and possibility of 
resistance development in Campylobacter against phenolic extracts. In vitro synergistic 





Holarrhena antidysenterica, Plumbago zeylanica, Camellia sinensis, Lawsonia inermis, Punica 
granatum, Terminalia chebula and Terminalia belerica were detected with tetracycline, 
chloramphenicol, ciprofloxacin, cefuroxime and ceftidizime (Aqil et al., 2005; Aqil et al., 2006). 
Antibiotic-phenolics combination studies have demonstrated synergistic relationship between 
streptomycin and phenolics including ferulic acid, gallic acid, allylisothiocyanate chlorogenic 
acid, and 2-phenylethylisothiocyanate against the Gram-negative bacteria (Saavedra et al., 2010). 
Bakar et al., (2012) reported synergistic relationship between flavanone hesperidin aglycon 
extracted from citrus fruits with vancomycin and oxacillin to inhibit vancomycin-intermediate 
Staphylococcus aureus (VISA) and Helicobacter pylori. Liu et al., (2009) found that kaempferol 
glycosides isolated from Laurus nobilis, kaempferol-3-O-alpha-L-(2'',4''-di-E-p-coumaroyl)-
rhamnoside and kaempferol-3-O-alpha-L-(2''-E-p-coumaroyl-4''-Z-p-coumaroyl)-rhamnoside, 
greatly potentiated anti-Methicillin Resistant Staphylococcus aureus (MRSA) activity of 
fluoroquinolones. They also found that the synergism was more prominent with hydrophilic 
fluoroquinolones, for example, norfloxacin and ciprofloxacin, but not with hydrophobic 
quinolones. These findings suggest potential role of polyphenols in rescuing traditional antibiotics 
against which bacterial resistance already have been developed. 
However, here comes the burning question, “what if bacteria becomes resistant to natural 
phenolics.”  There are no reports, so far, on the resistance of bacterial pathogens including 
Campylobacter against natural phenolics. Crude or purified plant phenolic extracts and their 
microbial metabolites make up an enormous array of diversified bioactive compounds, which 
come in contact with bacterial pathogens. These compounds attack the pathogens with varied 
mechanistic approach from different directions. Moreover, plant polyphenols have been a part of 
human and animal diet from pre-historic era and so, pathogenic bacterial resistance would have 
been reported earlier if the phenomenon was supported by the Mother Nature. Yet, experiments 














Overall Hypothesis and Specific Aims 
Natural bioactive components extracted from blackberry and blueberry pomaces can 
persistently reduce the colonization of Campylobacter in poultry gut while promoting gut health 
and poultry productivity. 
To investigate the hypothesis, the following aims need to be fulfilled, 
Aim 1: Extraction, composite analysis, and roles of berry pomace extracts on the growth and 
pathogenicity of Campylobacter jejuni. 
Aim 2: Determine the effects of berry pomace extracts on poultry pathogens of commercial 
importance and probiotics in vitro and cultured host cells ex vivo. 
Aim 3: Role of berry pomace extracts on Campylobacter jejuni colonization in poultry gut using 
day-old chick model. 
Aim 4: Berry pomace extracts on poultry growth promotion through modulation of gut 
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Table 1.1. FDA-approved antibiotics for pre-harvest subtherapeutic use in cattle, swine and 
poultry. 
Antibiotics Cattle Swine Poultry 
Apramycin  +  
Arsanilic acid  + + 
Avilamycin   + 
Avoparcin   + 
Bacitracin zinc + + + 
Bambermycins + + + 
Carbadox  +  
Chlortetracycline + + + 
Laidlomycin +   
Lasalocid +   
Lincomycin  + + 
Monensin + +  
Oxytetracycline + + + 
Penicillin  + + 
Roxarsone  + + 
Spiramycin   + 
Tilmicosin  +  
Tylosin + + + 












Table 1.2: Bioactive phytochemicals present in pomaces and their biological roles 
Compound Generalized chemical 
Structure 
 Targeted microorganism and 











Gram-positive bacteria and 
few Gram-negative bacteria 
Membrane damage and 
interaction with intracellular 
materials 
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Chapter 2: Extraction, composite analysis, and roles of berry pomace 
extracts on the growth and pathogenicity of Campylobacter jejuni 
 
Introduction 
Campylobacter jejuni is one of the major enteric pathogens and is the source of much of the 
foodborne bacterial illnesses in the US. In 2012, Foodborne Diseases Active Surveillance Network 
(FoodNet) identified 14.3 Campylobacteriosis cases for every 100,000 inhabitants of the twelve 
states of USA and this rate was 14% higher than the rates found in 2006-2008. This high prevalence 
rate may be attributed to the increased consumption of white meat specifically chicken and turkey. 
In recent years, poultry has been recognized to be the major source of Campylobacteriosis in 
humans (Lin, 2009). Campylobacter colonizes the poultry gut as part of the normal flora. So far, 
the most widely used control measure against the colonization of Campylobacter in poultry gut is 
the use of antibiotics in feed and water, but resistant strains of C. jejuni to several antibiotics, 
including ciprofloxacin, nalidixic acid, erythromycin, tetracycline, and streptomycin, have been 
reported (Wieczorek, Szewczyk, and Osek, 2012). Consequently, the search for alternative natural 
and organic antimicrobials is now more essential than ever. Bioactive phytochemicals from 
berries, especially blackberry (Rubus fruticosus) and blueberry (Vaccinium corymbosum) pomace 
as feed or water supplement to reduce pre-harvest level of C. jejuni contamination in poultry, might 
be a feasible alternative.  
Recently, the antimicrobial activity of phenolic compounds present in berry fruits and their 
pomaces against Campylobacter species and other intestinal pathogens was demonstrated (Biswas 
et al., 2012; Puupponen-Pimiä, Nohynek, Alakomi, and Oksman-Caldentey, 2005). Extraction of 
bioactive phytochemicals from fruit juice is too expensive for large scale application in the poultry 
industry. However, fruit pomace, the (semi) solid remains of crushed fruit after juice extraction, 
may provide a cheaper alternative. Fruit pomaces may make up as much of 30% of the original 
fruit weight and are produced in significant amounts in the US, where they are considered a waste 
product. Pomaces cannot be fed to animals directly since they are low in protein content and too 
acidic. Cheap extraction of the phenolics that are mainly responsible for the antibacterial action 





concentrated in the outer layers of fruit (e.g. skin) as their biosynthesis is dependent on UV-light 
(sunlight).  
Several modes of actions of berry phenolics have been suggested for pathogen inhibition. 
These mechanisms include damaging the bacterial cell membrane (Lacombe, Tadepalli, Hwang, 
and Wu, 2013), inhibition of extracellular microbial enzymes (Scalbert, 1991), direct effect on 
microbial metabolism, and deprivation of substrates mandatory for microbial growth (Puupponen- 
Pimiä et al., 2004). These mechanisms would act indiscriminately against benign and pathogenic 
bacteria. Nevertheless, we have provided evidence that berry juice inhibited pathogenic bacteria 
while stimulating the growth of probiotics (Yang, Hewes, Salaheen, Federman, and Biswas, 2014). 
The aim of this work was two-fold: (1) Development of a cheap extraction method to concentrate 
the antibacterial ingredients of berry pomace; and (2) Investigation of the effects of these active 
ingredients on the expression of virulence genes of C. jejuni, in order to explain the noted 
sensitivity of this pathogen for the antibacterial activity of berry pomace. The findings from this 
research will provide significant insight into the effects of blackberry and blueberry pomace 
extracts on C. jejuni growth, alteration of physicochemical properties, virulence gene expression 
and its interactions with host cells. 
 
Material and Methods 
Bacterial strain and growth condition. C. jejuni RM1221 (ATCC BAA-1062TM) was used in the 
current study. The bacterium was grown in Blood agar (Himedia, India) with 5% defibrinated 
sheep blood (Ward’s Science) at 37˚C under microaerophilic (10% CO2, 5% O2, and 85% N2) 
condition. 
 
Preparation of pomace extracts. Blackberry and blueberry whole fruits were purchased from a 
local market (College park, MD) and brought into the lab. A kilogram of blackberry or blueberry 
was treated with 1 liter boiling water for 3 minutes and the water was discarded. After cooling, a 
mixture of 400 mL sterile water and 82 µL (a rate of 0.0827 mL/kg of berry) pectinase enzyme 
(Novozyme Corp., Bagsvaerd, Denmark) was added to the treated berry and incubated at room 
temperature for 1 hour followed by vigorous blending. The pomace was concentrated by filtration 





the dark at 4˚C. For further analysis of pomaces that are produced commercially as by-products 
from the berry juice industry, we obtained blackberry and blueberry pomaces from Milne Fruit 
IncTM. 
Extraction was tested with the following solvents: water, 10% v/v ethanol and 10% v/v 
methanol. 2.5 g pomace was suspended in 50 mL extraction solution and incubated for 24 hours 
at 37 and 60˚C. After 24 hours, the solid portion was separated using centrifugation (3000 x g for 
20 min) and the supernatant was sterilized with 0.45 µm filter (AcroVac Filter Unit, Pall Life 
Sciences, NY). The solvent was evaporated by vacuum freeze drying and resuspended in deionized 
water. 
 
Determination of total phenolic contents in pomace extracts. Total phenolic content in each extract 
was determined using the spectrophotometric method described previously (Singleton, Orthofer, 
and Lamuela-Raventos, 1999). Briefly, 20 µL extract was dissolved to 1.58 mL water and 100 µL 
Folin-Ciocalteu reagents (MP; CAT NO.195186) was added. 300 µL 7.5 % Na¬2CO3 was added 
to the mixture and allowed to leave for another 2 hours at room temperature. The absorbance was 
determined with spectrophotometer (PerkinElmar, Lambda Bio) at λmax = 765 nm. The similar 
procedure was applied using standard solutions of Gallic acid and the standard calibration curve 
was constructed. To construct the calibration curve, 50 mL 10 mg/mL Gallic acid stock solution 
was prepared and 0, 0.25, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0 mg/mL Gallic acid solutions were formulated 
from the stock solution for individual points in the curve. The total phenolic content was expressed 
as Gallic Acid Equivalent (GAE). 
Determination of minimum inhibitory concentration of pomace extracts against C. jejuni. 
Minimum Inhibitory Concentration (MIC) was determined using broth micro-dilution method 
described previously (Nkanwen, Gatsing, Ngamga, Fodouop, and Tane, 2009). The concentration 
ranging from 0.0 mg/mL to 1.0 mg/mL GAE for both blackberry and blueberry pomace extracts 
were added to Bolton broth with 10% defibrinated blood to a final volume of 990 µL. 10 µL 
bacterial suspensions containing approximately 5×105 CFU/mL was added to each of the well of 
24-wells plates. Plates were incubated for 24 and 48 hours at 37˚C under microaerophilic 
condition. MIC was recorded as the lowest concentration of blackberry and blueberry pomace 





Minimum Bactericidal Concentration (MBC) was determined by culturing the last well 
showing visible growth and the wells with no visible growth on a Karmali Campylobacter Agar 
(HIMEDIA). The lowest concentration that caused a significant reduction compared to the control 
(>3-logs, 99.9%) was considered as MBC. MBC:MIC ratio was also determined which illustrates 
a relationship between in vitro minimum bactericidal concentration and MIC of any drug against 
specific pathogen. If the value is less than 2, the drug is considered to be bactericidal against that 
pathogen; if this ratio exceeds 16 the drug is considered bacteriostatic and the ratio is more than 
32, the pathogen is regarded to be tolerant to that drug (May, Shannon, King, and French, 1998; 
Konaté et al., 2013). 
Time dependent growth patterns of C. jejuni in the presence of various concentrations of 
blackberry or blueberry pomace extracts were also determined. Bacterial inoculum was prepared 
as described above and inoculated into broth containing various concentrations blackberry or 
blueberry pomace extracts. Deionized water was used in the control instead of berry pomace 
extracts. Bacterial solutions were diluted in PBS, plated on Karmali Agar plates and CFU was 
counted at various time points upto 72 hours. 
 
HPLC-tandem mass spectrometry (LC-MS/MS) analysis. Extracts were was prepared from the 
dried phenolic powder in 10% v/v ethanol and the total phenolic contents were measured. The 
concentrations of the stock solutions were adjusted to 6-8 g GAE/L. Berry pomace extract (BPE) 
was comprised of blackberry and blueberry pomace extracts at 1:1 v/v ratio. Total phenolic content 
in each extract was determined using spectrophotometric method (Singleton et al., 1999) and 
expressed as Gallic Acid Equivalent (GAE). The pH of the crude extracts were 4.5-5 and pH varied 
depending on the treatment concentration. A phenolic screen was accomplished using HPLC-MS 
(Peng et al., 2014).  Sample injections were 5 µL and separations were performed on an Agilent 
1100 system, coupled to an Agilent MSD-TOF (time-of-flight) mass spectrometer.   Reversed-
phase liquid chromatography was used to separate the samples.  A Waters Atlantis T3 column (3 
µm, 150 x 2.1 mm i.d.) was used.  A binary mobile phase consisting of solvent systems A and B 
was used in gradient elution where A was 0.1% formic acid (v/v) in ddH2O and B was 0.1% formic 
acid (v/v) in acetonitrile.  Mobile phase flow rate was 0.3 mL/min.  The linear gradient was as 
follows:  time 0 – 1 minute, 0% B; time 40 minutes, 90% B; time 41 minutes, 90% B; time 42 





introduced by electrospray ionization (ESI) into the MSD-TOF.  Samples were assayed, using both 
negative and positive mode ESI.  Source parameters were:  gas temperature 350˚C, gas flow 9 
L/min, nebulizer 35 psi, fragmentor 125 V, capillary voltage 3500 V.  Data were acquired with a 
mass range of 75 - 1000 m/z.  Accurate mass accuracy was guaranteed by the continuous infusion 
of Agilent Reference Mass Solution (G1969-85001). Individual chromatographic peaks were 
identified using Agilent’s Mass Hunter Qualitative Analysis software (v. B.06).  Compounds were 
identified using Agilent’s Mass Profiler Professional software (v. 13.1).  Peaks in duplicate 
injections were aligned to account for instrumental drifts in retention time and mass.  Compounds 
were retained only if they appeared in both duplicate samples.  Compounds were annotated by 
querying Agilent’s METLIN human metabolite database, with a mass error criteria of < 5 ppm. 
 
Evaluation of physicochemical properties C. jejuni treated with pomace extracts  
Hydrophobicity: The bacterial cells were grown in the absence (no treatment) and 
predetermined sublethal (concentration at which reduced but not complete growth inhibition is 
observed) concentrations of blackberry/blueberry pomace extracts at 37˚C for 18 h. Cells were 
suspended in 2 mL of phosphate buffer saline (PBS, pH 7.2) and optical density (OD) was adjusted 
(OD570) to 0.5 (Ht0). The solution was mixed with 1 mL of n-hexadecane and incubated for 5 
min at room temperature. The aqueous phase was measured at 570 nm (Ht5) using microplate 
reader (Multiskan FC, Thermo Scientific, MA). The hydrophobicity was calculated using the 
equation:  Hydrophobicity (%) = (1 – Ht5/Ht0) × 100. 
Auto-aggregation: The bacterial cells were incubated at 37˚C for 24h either in only broth 
(control) or broth supplemented with blackberry or blueberry pomace extracts. The cells were 
centrifuged at 3,000 × g for 20 minutes, the supernatant was decanted, and the cells were 
resuspended in 3 mL of PBS (pH 7.2) and adjusted the OD  (OD570)  to 0.5 (At0). The cell 
suspensions were incubated at 37 ˚C for 2h. The supernatants were separated and absorbencies 
were measured using a Multiskan microplate reader at 570 nm (At2). Aggregation was expressed 
as Auto-aggregation (%) = (1 – At2/At0) × 100. 
Swimming and swarming motility: Motility assay was performed on semi-solid medium 
as described previously (Golden, 2002). In brief, OD600 of C. jejuni suspension was adjusted to 
0.10. Two µL of the bacterial suspension was stabbed onto 0.45% (swarming motility) or 0.25% 





extracts. For negative control, equal amount of water was added to the wells. The plates were 
incubated at 37˚C for 48 hours under microaerophilic condition and diameter of zone for control 
(ZDC) and treatments (ZDT) were measured and calculated following the equation: 
Motility rate (%) = ZDT/ ZDC × 100. 
 
Adhesion and invasiveness assay. Adherence and invasiveness assays were performed according 
to the method described previously (Biswas et al., 2000). Briefly, 100 µL bacterial suspension, 
containing CFU approximately 100 times higher than host (INT-407 or DF-1) cell number, was 
inoculated into triplicate wells of a 24-well tissue culture plate. Each well contained semi-
confluent monolayers of INT- 407 or DF1 cells covered with DMEM with 10% Fetal Bovine 
Serum (FBS) and 0.10 mg/mL and 0.08 mg/mL GAE of blackberry and blueberry pomace extracts 
respectively to a final volume of 900 µL. Infected monolayers were incubated for 3 h at 37˚C under 
a 5% CO2 humidified atmosphere. The infected monolayers were washed five times with DMEM 
containing 1% FBS and then re-incubated for another 1 h in fresh DMEM containing 10% FBS 
and 250 µg/mL of gentamicin. The monolayers were washed three times with DMEM containing 
1% FBS and lysed with 0.1% Triton X-100 for 15 min. The suspensions were diluted and the 
numbers of viable bacterial cells were determined on Karmali agar plates.  
 
RNA extraction and cDNA synthesis. The cells were grown in the absence or presence of sub-lethal 
concentrations of blackberry and blueberry pomace extracts and the extraction of RNA was carried 
out according to the protocol of ZR Bacterial RNA MiniPrep kit (Zymo Research Corp., Irvine, 
CA). RNA quantification was carried out using a NanoDrop spectrophotometer (Thermo Scientific 
Inc., West Palm Beach, FL). The cDNA synthesis was performed according to the protocol of 
qScript cDNA SuperMix (Quanta Biosciences, Gaithersburg, MD). The eluted RNA (1 µg) was 
mixed with 4 µL of 5X qScript cDNA SuperMix containing optimized concentration of MgCl2, 
dNTPs, RNase inhibitor protein, qScript reverse transcriptase, random primers, oligo(dT) primer, 
and stabilizers and then incubated at 25˚C for 5 min, 42˚C for 30 min, and 85oC for 5 min.  
 
Quantitative RT-PCR assay. The mixture containing 10 µL of PerfeCTa SYBR Green FastMix, 2 
µL of each primer (100 nM), 2 µL of cDNA (10 ng), and 4 µL of RNase-free water was amplified 





followed by 40 cycles of 95°C for 5 sec, 55°C for 15 sec, and 72°C for 10 sec. The custom-
synthesized oligonucleotides (Erofins MWG Operon; Huntsville, AL) used as primers to target 
conserved regions of C. jejuni are listed in Table 2.2. The relative expression levels of genes were 
calculated by the comparative method (Livak, and Schmittgen, 2001). The CT values of target 
genes in treated C. jejuni cells were compared to the CT values obtained from the control. The 
housekeeping gene, 16S ribosomal RNA, was used as the reference gene for normalization of 
target gene expression. 
 
Statistical Analysis. All data were analyzed using the Statistical Analysis System software (SAS, 
Institute Inc., Cary, NC, USA). One-way analysis of variance (ANOVA) was used, followed by 































Role of solvents on phenolic content extraction from pomaces. We have extracted the pomace 
phenolics using three different solvents (10% ethanol, 10% methanol in water, and water alone) 
and incubated at two different temperatures, 37˚C or 60˚C, (Table 2.3). We found that as a solvent, 
10% ethanol in water was the most effective in extracting phenolic compounds from both 
blackberry (1.66 mg/mL GAE) and blueberry (1.43 mg/mL GAE) pomaces compared to other two 
solvents though the difference between ethanol and methanol in terms of extracting phenolic 
compounds was not significant. Due to toxicity issue, we further used ethanol as solvent. We also 
observed that 95% ethanol in water failed to extract the phenolic compounds in pomaces. In the 
presence of 95% ethanol in water, the mixture became too hazy (data not shown). Water alone was 
found to be the least effective in extracting the phenolic contents of pomaces. We observed that 
10% methanol in water could extract the phenolic compounds in pomaces (1.55 mg/mL and 1.35 
mg/mL GAE from blackberry and blueberry pomaces respectively) better than water alone (0.75 
mg/mL and 0.51 mg/mL GAE from blackberry and blueberry pomaces respectively) but lower 
than 10% ethanol in water extraction (1.66 mg/mL and 1.43 mg/mL GAE from blackberry and 
blueberry pomaces respectively). We also found that temperature had a significant impact on total 
phenolic content. A higher temperature (60˚C) had significant impact in extracting phenolic 
compounds from both blueberry and blackberry pomaces compared to a lower temperature (37˚C). 
Among all the solvents and temperatures, we found that 10% ethanol in water extracted the highest 
amount of phenolic compounds in berry pomaces at 60˚C. 
 
Composition of BPE. BPE solution remained stable (no significant change in total phenolic 
content) at room temperature upto 1 month in room temperature and 6 months under refrigerated 
condition. HPLC-MS analysis of these crude extracts with negative and positive ionization mode 
showed the presence of a wide array of components (Supplementary file 1). In the negative 
ionization mode, 5108 (2320 unique) and 4445 (2221 unique) compounds were detected in 
blackberry and blueberry pomace extracts, respectively (Table 2.1). Major compounds in these 
extracts included, but not limited to, apigenin, acetoxyeugenol, chlorogenic acid, cinnamic acid, 





hydroxydaidzein, myricetin, phenols, quercetin, quinones, rhamnosides, stilbenol, triamcinolone, 
and xanthine. Wide structural variability in the phenolic derivatives were observed. 
 
Inhibition of C. jejuni growth with pomace extracts. The effect of blackberry and blueberry pomace 
extracts on C. jejuni growth is shown in Table 2.4. We found that MIC and MBC of blackberry 
pomace extract were 0.6 mg/mL and 0.8 mg/mL GAE respectively, whereas MIC and MBC of 
blueberry pomace extract were 0.4 mg/mL and 0.5 mg/mL GAE. MBC:MIC ratio shows values < 
2 for both of the extracts which indicates both of them are bactericidal (Table 2.4) but the 
bactericidal activity of blueberry pomace extract was stronger than that of blackberry pomace 
extract. 
 
Time required for inhibition of growth of C. jejuni with pomace phenolic extracts. Based on the 
previous results showing growth inhibition and bactericidal effect of blueberry and blackberry 
pomace extracts on C. jejuni growth, we monitored the growth inhibition at various time points. 
The CFU/mL of the C. jejuni strain incubated in different concentration of blackberry and 
blueberry pomace extracts were reduced in a time-dependent manner. In Fig. 2.1, we showed the 
time dependent inhibition of C. jejuni in the presence of various concentrations of berry pomace 
extracts. We observed that the same concentration (0.6 mg/mL GAE) of blackberry and blueberry 
pomace extract showed difference in growth inhibition. 0.6 mg/mL GAE of blackberry pomace 
extract reduced the CFU/mL of C. jejuni approximately 2 logs compared to the control at 24 h 
time point. In the same experiment, 0.6 mg/mL GAE of blueberry pomace extract reduced the 
CFU/mL of C. jejuni approximately 6.5 logs after 24 hours of incubation compared to the control. 
Though inhibition of C. jejuni growth with 0.8 mg/mL GAE blackberry pomace extract was > 4 
logs after 24 hours compared to the control (recorded as MBC), but growth inhibition was not 
observed during the first six hours at the ranges of concentrations from 0.6 to 0.7 mg/mL GAE. 
On the other hand, higher concentrations of blueberry pomace extract (0.5 mg/mL GAE) showed 
antimicrobial effect right from the beginning of the growth cycle of C. jejuni (Fig. 2.1).  
This fact was further supported when inhibition of growth pattern of C. jejuni was observed for 
longer periods of time in the presence of sub-lethal concentrations (0.3 mg/mL GAE) of both of 
the blackberry and blueberry pomace extracts. Blackberry pomace extract showed mild inhibitory 





started to lose effectiveness after 24 hours while blackberry retained effective even after 72 hours 
providing > 2 log reduction compared to the control. 
 
Alteration of virulence properties of C. jejuni in the presence of pomace extracts. In this study, in 
the presence of blueberry or blackberry pomace extracts, autoaggregation capability of C. jejuni 
strain decreased significantly (Table 2.5). Untreated bacterial cells showed higher autoaggregation, 
nearly 66% whereas in presence of blackberry and blueberry pomace extracts the values were 
reduced to 62% and 42%, respectively. But cell surface hydrophobicity of C. jejuni was increased 
by treating with both berry pomace extracts. The motility phenotypes of C. jejuni treated with 
berry pomace extracts were examined through solid-based movement (swarming motility) and 
liquid-based movement (swimming motility) on semi-solid agar plates containing berry pomace 
extracts (Table 2.5). Both blackberry and blueberry pomace extracts reduced bacterial migration, 
while strong migration was observed in the absence of pomace extracts (Fig. 2.2). We found that 
blackberry pomaces extract reduced the motility of C. jejuni more effectively (>85%) than 
blueberry pomace extract (<40%). 
 
Role of berry pomace extracts on host cell-C. jejuni interactions. Invasion of C. jejuni into INT407 
cells and DF1 cell was reduced significantly (Fig. 2.3) in the presence of low concentrations of 
berry pomace extracts (0.10 mg/mL and 0.08 mg/mL GAE of blackberry and blueberry pomace 
extract respectively). The concentrations of pomace extracts were selected depending on their 
cytotoxic effect on cultured (INT-407 and DF1) cells (data not shown). In the presence of 
blackberry and blueberry pomace extracts, reduction of invasion abilities of C. jejuni into DF1 
cells were >75% and >30%, respectively. In INT407 cells, invasion abilities of C. jejuni were also 
reduced similarly, approximately 79% in the presence of blackberry and approximately 52% in the 
presence of blueberry pomace extracts, respectively. We also observed that both blueberry and 
blackberry pomace extracts also reduced the adhesion abilities of C. jejuni to DF1 cells 
significantly, but not to INT407 cells. Adhesion abilities of C. jejuni to DF1 were reduced by 42% 
and 29% in the presence of blackberry and blueberry pomace extract, respectively whereas 
adhesion abilities of C. jejuni to INT407 cells were reduced by 19% and 27% in the presence of 





We also carried out an experiment where bacterial cells were pretreated with pomace 
extracts before infection phase. We needed to collect the cells with centrifugation for infecting 
host cell. We found that centrifugation at 3000×g for 20 min reduced the adhesion or invasiveness 
of C. jejuni RM1221 (data not shown). 
 
Role on virulence gene expression. The common and known genes responsible for C. jejuni 
adherence and invasion ability and bacterial cell motility were examined for their expression in 
the absence or presence of two different concentrations (0.6 and 0.4 mg/mL GAE blackberry and 
0.4 and 0.2 mg/mL GAE blueberry) of blackberry and blueberry pomace extracts (Fig. 2.4). In 
both concentrations, blackberry pomace extract increased the expression of flaA by 3 to 5 fold. 
Expression level of the other genes, including flaB, cadF, ciaB and cdtB, did not alter significantly. 
But we observed the numerical decrease in cadF in the presence of blueberry pomace extracts at 

































There are many natural components that are able to limit and inhibit the spread and virulence of 
foodborne bacterial pathogens. In our previous study, we found that both blueberry (Biswas et al., 
2012) and blackberry (Yang, Hewes, Salaheen, Federman, and Biswas, 2014) juice inhibited the 
growth of various foodborne bacterial pathogens including C. jejuni. Several literatures also 
indicated that phenolic components of berry and berry products have antioxidant and offer many 
other health benefits (Biswas et al., 2012; Puupponen-Pimiä, Nohynek, Alakomi, and Oksman-
Caldentey, 2005). Considering the economical and practical approach of using bioactive 
components of berries in agricultural animal production, in this study we initiated an innovative 
method to extract the bioactive components from the byproduct of the blueberry and blackberry 
juice industry. We also tested the role of these bioactive extracts of berry pomaces in the cellular 
and molecular properties and dynamics of interaction with host cells of C. jejuni. Our results 
suggested that berry pomace extracts used as feed additives or water supplements may reduce the 
colonization level of C. jejuni in poultry. Though the nontoxic concentration of phenolic extracts 
of berry pomace could not stop complete growth of C. jejuni, it reduced the growth significantly. 
A risk assessment study found that C. jejuni infection in humans could be reduced by 30-fold if 
the number of this pathogens in poultry was reduced by 2 logs (Rosenquist, Nielsen, Sommer, 
Nørrung, and Christensen, 2003). 
Berry pomaces are rich in phenolic compounds making them a plausible source for 
extraction. Proper application of these cheap and vastly abundant byproducts could help reduce 
the waste management problems in the juice industries and increase their profits. In this study, we 
focused on the extraction of bioactive components from the pomace of locally grown blueberry 
and blackberry and investigated the role of these the bioactive extracts against the most common 
foodborne pathogenic enteric bacteria, C. jejuni.  
We extracted the pomace phenolics using different concentrations of three solvents and 
two incubation temperatures. We found that as a solvent, 10% ethanol in water and 60˚C 
incubation temperature was the most effective in extracting phenolic compounds from both 
blackberry and blueberry pomaces. In our study, 10% ethanol solution served more efficiently in 
extracting phenolics from berry pomaces compared to 10% methanol in water or water alone. This 





efficient than methanol in extracting polyphenols. Moreover, the toxicity issue favors ethanol over 
methanol as solvent. Temperature is another important variable that affects polyphenol extraction 
and higher extraction temperature (60˚C) was found to increase the amount of total phenolics 
regardless the types of solvent (Pinelo, Rubilar, Jerez, Sineiro, and Núnez, 2005; Spigno and De 
Faveri, 2007). We also found extraction temperature of 60˚C was more efficient compared to 37˚C, 
which is in complete agreement with previous findings.  
Previous studies focused on the ability of berry phenolics to inhibit pathogens (Nohynek 
et al., 2006) or the MIC of different phenolics against C. jejuni (Klancˇnik, Mozˇina, and Zhang, 
2012). In addition to that, we focused on the growth pattern of C. jejuni in the presence of sub-
lethal concentrations of blackberry and blueberry pomace phenolics. Both blackberry and 
blueberry pomace extracts were proved to be bactericidal considering the MBC:MIC ratio. Higher 
concentration of blackberry pomace extract was required to get similar bactericidal effect to its 
blueberry counterpart. But a sub-lethal concentration of blackberry pomace extract exerted long 
term bactericidal effect, even after 72 hours of bacterial growth, whereas a sub-lethal concentration 
of blueberry pomace extract started to lose effect after 24 hours. There might be difference in 
polyphenol composition between these two pomaces extracts. Berries contain four major classes 
of phenolic compounds: flavonoids, phenolic acids, lignans, and polymeric tannins (Puupponen-
Pimiä, Nohynek, Alakomi, and Oksman-Caldentey, 2005) and we hypothesize compositional 
differences might be the reason for the different effects of blackberry and blueberry pomace 
extracts on C. jejuni. 
This study also found that blackberry and blueberry pomace extracts altered several 
virulence properties of C. jejuni. Two important physicochemical surface properties of pathogenic 
bacteria are autoaggregation and hydrophobicity. Autoaggregation is considered to be a marker of 
virulence in several Gram-negative bacteria (Chiang, Taylor, Koomey, and Mekalanos, 1995; 
Menozzi, Boucher, Riveau, Gantiez, and Locht, 1994). Though role of autoaggregation in C. jejuni 
pathogenesis is not well documented, it has been suggested that autoaggregation might play role 
in C. jejuni invasiveness into intestinal epithelial cells (Golden, 2002). We found that due to 
treatment with sublethal concentration of blueberry pomace extracts, C. jejuni autoaggregation 
decreased significantly whereas blackberry pomace extract caused numerical decrease (but not 
significant) in autoaggregation. Hydrophobicity is another important surface physicochemical 





to bacterial adhesion (Saran, Bisht, and Singh, 2012). Some studies have suggested that there is no 
correlation between hydrophobicity and autoaggregation or bacterial attachment (Vinderola, 
Medici, and Perdigón, 2004). We observed that treatment with berry pomace extracts caused an 
increase in C. jejuni surface hydrophobicity unlike autoaggregation, which decreased significantly. 
Both in vitro and in vivo study indicated that motility also plays a critical role in 
pathogenicity of C. jejuni (Yao et al., 1994). In this study, we investigated the motility phenotypes 
of C. jejuni in presence of sublethal concentration of blackberry and blueberry pomce extracts in 
liquid-based movement (swimming motility) and solid-based movement (swarming motility) on 
semi-solid agar plates. Both kinds of motility decreased significantly in the presence of both 
pomace extracts, though C. jejuni seemed less motile in the presence of blackberry rather than 
blueberry pomace extract. It has also been found that natural carvacrol reduced C. jejuni motility 
by disrupting the function of flagella (Van Alphen, Burt, Veenendaal, Bleumink-Pluym, and van 
Putten, 2012), but this treatment did not alter flagellar biosynthesis, which is in complete 
agreement with our findings. The flagella-mediated swimming motility is mainly responsible for 
bacterial translocation to evade the host immune system (Chow, Gu, Jiang, and Nassour, 2011). 
The surface-associated swarming motility plays critical role in bacterial colonization (O'May and 
Tufenkji, 2011). The decrease in swimming and swarming motility indicates that blackberry and 
blueberry pomace extracts can effectively control bacterial interactions with host cells. 
Attachment is the major prerequisite for colonizing C. jejuni on intestinal epithelial cells 
and invasiveness is considered to be an important virulence property. Adhesion and invasion 
abilities of C. jejuni to the cultured human intestinal epithelial (INT407) cells and chicken 
fibroblast (DF1) cells were compared in the presence and absence of blueberry and blackberry 
pomace extracts. Significant decrease in invasiveness into both cell lines were observed and 
numerical decrease in adhesion were found. The above mentioned paralyzed physicochemical 
properties (decreased autoaggregation and mitility) might have impact on the reduction of 
adherence and invasion abilities of C. jejuni. The findings agrees with the previous report (Golden, 
2002) which also showed that decreased motility caused reduction in invasiveness in C. jejuni.  
We assessed the expression level of several virulence genes of C. jejuni. The genes include 
flaA (Flagellin A subunit synthesis), flaB (Flagellin B subunit synthesis), cadF (Campylobacter 
adhesion fibronectin-binding protein), cdtB (Cytolethal distending toxin) and ciaB 





observed, but the expression of other genes under study remained unaltered. The mechanism 
behind the increase in flaA expression is still unknown, but it plays an important role in 
pathogenesis, specifically the motility and colonization of C. jejuni. We hypothesize, disruption of 
flagellar integrity due to BPE treatment may be compensated with induction of flaA. To our 
knowledge, this study is the first report exploring the expression level of virulence genes of 







































1. Major compounds in BPE included, but not limited to, apigenin, catechol, chlorogenic acid, 
cinnamic acid, coumarin, ellagic acid, eugenols, flavan, gallic acid, gingerol, glucosides, 
glucuronides, myricetin, phenols, quercetin, quinones, rhamnosides, stilbenol, tannins, 
triamcinolone, and xanthine. 
2. BPE inhibited the growth of C. jejuni in vitro and altered physicochemical properties of 
bacterial cell membrane. 
3. BPE reduced C. jejuni growth and motility, in vitro, resulting in lower adherence and 
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No. of unique 
compounds 
Blueberry Pomace Extract (+) ve 1103 605 
Blueberry Pomace Extract (-) ve 4445 2221 
Blackberry Pomace Extract (+) ve 1638 985 
Blackberry Pomace Extract (-) ve 5108 2320 





















Table 2.2. Molecular functions and primer sequences of target genes used in qRT-PCR analysis 
for C. jejuni 
Function/prot
ein 
Gene Primer Sequences (5’-3’) References 
Flagellin A flaA Forward GCAGCAGATGATGCTTCAGGGAT Klančnik et al., 
2006 Reverse GCTTGAAGCATGGTTCTTGT 













cdtB Forward AATGCAAGCTGAAGAAGTGATTGT Lara-Tejero, and 









Forward AGAGTTTGATCCTGGCTCAG Klančnik et al., 


















Table 2.3. Total phenolic content in blackberry and blueberry pomace extracts in presence of 
different solvents 
Source Extraction Solvent Extraction Temperature 
(˚C) 
Total Phenolic Content 
(mg/mL GAE) 
Blackberry 10% Ethanol 60 1.66 ± 0.30 
37 0.75 ± 0.25 
10% Methanol 60 1.55 ±0.42 
37 0.79 ± 0.19 
Water 60 0.75 ± 0.23 
 
Blueberry 10% Ethanol 60 1.43 ± 0.18 
37 1.09 ± 0.21 
10% Methanol 60 1.35 ± 0.31 
37 0.98 ± 0.19 




















Table 2.4. Antibacterial effect of blackberry and blueberry pomace extracts on C. jejuni 








0.6 0.8 1.33 Bactericidal 
Bluebery pomace extract 0.4 0.5 1.25 Bactericidal 
Abbreviations: MIC, Minimum Inhibitory Concentration; MBC, Minimum Bactericidal 






















Table 2.5. Physicochemical properties and mechanical behaviours of C. jejuni treated with 
blackberry and blueberry pomace extracts.  
Treatments Auto-aggregation 
(%) 




     
Control 66.45±3.08 ǂ, a 1.27±0.74 a 100₳, a 100 a 
Blackberry pomace 
extract 
62.36±0.37 a 4.16±2.81 a 10.02±0.50 b 14.04±1.46 b 
Blueberry pomace 
extract 
42.64±5.42 b 7.17±1.40 b 71.45±7.21 c 60.51±9.53 c 
ǂ Means with different letters within an individual column (a-c) are significantly different at P < 
0.05. 




















Fig. 2.1. Time dependent growth inhibition pattern of C. jejuni in presence of various 
concentrations (in mg/mL GAE units) of blackberry (A) or blueberry (B) pomace extracts. 
Comparative growth inhibition of blackberry and blueberry pomace extracts at particular 





































































































Fig. 2.2. Swimming and swarming motility of C. jejuni in presence of pomace extracts. 
























Fig. 2.3. Adhesion (A and C) and invasiveness (B and D) of C. jejuni to INT407 cells and DF1 
respectively in presence of blackberry and blueberry pomace extracts. Means with different letters 











































































































Fig. 2.4. Relative expression of virulence genes of C. jejuni treated with (A) 0.4 mg/mL GAE 
blackberry, (B) 0.2 mg/mL GAE blueberry, (C) 0.6 mg/mL GAE blackberry, and (D) 0.4 mg/mL 
GAE blueberry pomace extracts. * indicates significantly increased or decreased relative 








































































































Chapter 3: The effects of berry pomace extracts on poultry pathogens of 
commercial importance and probiotics in vitro and cultured host cells ex 
vivo. 
Introduction 
Maintaining the health of food-animals health is important from an animal welfare, animal 
production and public health standpoint. The health status of the poultry is always critical to the 
producer whether he maintains a backyard or commercial poultry flock. Identification of the cause 
of disease and appropriate treatment or adequate feeding can prevent a condition from becoming 
an unprofitable enterprise due to poor production and quality of the birds. Several bacterial 
pathogens are involved in poultry diseases and economic losses caused by them are currently 10 
to 20 percent of the gross value of production in developed poultry industries and are likely to be 
higher in organic/pasture farming (Fanatico 2008; Hanning et al 2010). Major bacterial diseases 
such as fowl typhoid, caused by Salmonella enterica serovars Gallinarum and Pullorum, and fowl 
cholera, caused by Pasteurella multocida remain a large threat to the poultry industry specifically 
pastures poultry (Porter 1998; Christensen and Bisgaard 2000; Herath et al 2010). Recently, it has 
been found that most of the gastrointestinal diseases and animal health are strongly influenced by 
gut flora and gut floral composition can be modulated with feeds (Backhed et al 2012). 
Pasteurella multocida is one of the most common poultry pathogen which causes highly 
fatal disease known as fowl cholera (Herath et al 2010). Fowl cholera has a great economic impact 
in large and small scale poultry productions including both organic and conventional back-yard 
poultry production. The disease has global occurrence and is capable of infecting all avian species 
(Christensen et al 2000, Herath et al 2010). In addition with fowl cholera, P. multocida also cause 
lameness and neurological disorder in poultry and several other diseases in cattle (bovine mastitis) 
and pig (diarrhea) (Wilkie et al., 2012). In early age mortality of poultry is one of the biggest 
hurdles of poultry industries and this pathogen play a key role. 
Currently, free-range and pasture-flock poultry is a sustainable agricultural production 
system and up on the rise on the top of the organic food lists (Adl et al., 2011). It is becoming more 
popular due in part to a negative perception of conventionally raised chicken. Free-range and 
pasture-flock poultry spend more than half of their life in outdoor open areas and come in contact 





risk of various infectious diseases are major concerns for free-range and pasture-flock poultry. 
According to national organic regulations, organic livestock farming is not allowed to use 
antibiotics and other synthetic chemicals. Instead of routinely giving antibiotics to their animals, 
organic farmers try to keep animals healthy through proper nutrition and sanitation, by reducing 
animal stress and with preventative and holistic animal health practices. But without chemical and 
antibiotics, organic farm animals specifically poultry tend to become more susceptible to various 
bacterial infectious diseases. Fowl cholera is recognized as a big player in pasture and free-range 
poultry and the disease pose a serious threat to gastrointestinal health and overall flock livability 
and mortality (Porter 1998). 
A Danish survey of large organic layer flocks reported high mortality rates (15-20%) of 
two to three times higher than layers in conventional battery cages (Kritensen 2012). In a 
manuscript entitled “Causes of mortality in commercial organic layers in Denmark” Stckholm et 
al (2010) reported that the mean of flock mortality for organic layers was 20.8% compared with 
7% for confined flocks on deep litter (Hanning et al 2011).  In the US, broiler mortality rates vary 
from 5 to 10 percent in organic production and this numbers for organic layer flocks are from 3 to 
5 percent (Fanatico 2008). That indicates that due to higher mortality, organic farmers lose millions 
of dollars every year in the US. 
The most common and available current option for controlling poultry diseases in poultry 
flocks is the addition of synthetic antimicrobials to poultry feeds and water and/or vaccination. 
Due to poor efficacy and inconvenience in use in poultry flocks, most of the farmers prefer to use 
antibiotics for disease control as well as growth promotion. But, according to the USDA 
recommended substances removal from the NOP’s National List, organic poultry farmers are not 
allowed to use those antimicrobial chemicals for their flocks for either disease control or growth 
promotion. Moreover, pasture flocks and free-range chickens are raised with access to the outdoors 
for at least one-third of their entire life cycle (Hanning et al 2010). The lack of proper biosecurity 
measures potentially increases the possibility of their coming into close contact with sources of 
foodborne pathogens including birds, pests and other wild animals (Hanning et al 2010). Organic 
farmers are in need of natural antimicrobial products to employ in disease control and to improve 
the gut flora of the birds in order to maintaining the flocks’ good health and sustain their business 





Berries, native North American fruits and their byproducts (pomaces) are of interest to 
researchers because of their potential market value and contribution to human health as well as 
their strong antimicrobial effect. Berries are rich in several phytochemicals such as phenolic acids, 
proanthocyanidins, anthocyanins and other flavonoids (Bomser et al 1996; Mantley and Buslig 
1998). Many of these compounds exhibit a wide range of biological effects including antioxidant, 
antimicrobial, anti-inflammatory and vasodilators (Mantley and Bushlig 1998). The antimicrobial 
activity of these compounds has been intensively studied as a means to control invasion by and 
growth of plant pathogens (Boivin et al 2007; Jepson and Craig 2007).  There has been growing 
interest in a variety of potential chemo preventive activities of edible berries, specifically 
blueberry, blackberry and cranberry. Pomace (byproducts) consists primarily of seeds and skins of 
fruits used for juice and wine production and shows antimicrobial activity against various bacterial 
pathogens. There is evidence that flavanols that reach the large intestine may provide prebiotic-
like benefits by promoting the growth of beneficial bacteria while inhibiting the growth of harmful 
bacteria (Tzounis et al 2011; Salaheen et al 2014). Since uses of fruit pomaces are limited, fruit 
processing industries are becoming increasingly interested in exploring alternate and potentially 
economically advantageous ways to utilize their waste materials. Given the emphasis on the 
potential application of the bioactive extracts of the blueberry and blackberry pomaces in poultry 
disease control and on improved gut flora, it is critical to provide in depth research-based 
information that will aid in a demonstrating clear evidence of the functional roles of these extracts 
as allowable alternatives to substances recommended for removal from the NOP’s National List 
of Prohibited Substances specifically antibiotics. The aim of this study is to develop an alternative 
bioactive intervention strategy for common poultry diseases and improve the gut flora using 
functional extracts of berry pomace (byproducts). We hypothesize that bioactive components from 
the byproducts of blueberry and blackberry will be an alternative functional agent for gut flora 
modulation and control of bacterial poultry diseases such as fowl cholera and fowl typhoid. In 







Material and Methods 
Bacterial strains and growth conditions. Pasteurella multocida (ATCC 15742) was used in this 
study. Prior to each experiment, bacterial strain was cultured on blood agar plates containing 5% 
sheep blood (SBA) at 37°C for 18 h. As liquid medium, tryptone soy broth (Oxoid) and for 
counting Luria Bertani (HIMEDIA) were used for experimental purpose. Salmonella enterica 
serovars Gallinarum (CAT375, Presque Isle Cultures, Erie, PA) and Pullorum (CAT3751, Presque 
Isle Cultures, Erie, PA) were used as poultry bacterial pathogens and Lactobacillus plantarum 
(ATCC 8014TM) was used as a probiotic. Prior to each experiment, S. Gallinarum and S. Pullorum 
were grown on Luria Bertani (LB) (Himedia, India) agar plate and L. plantarum was grown on 
deMan, Rogosa, and Sharpe (MRS) agar (EMD, MA) plates at 37°C for 18-24 h from -80°C 
glycerol stock. Afterwards, for growth inhibition assay and colony counting LB or MRS agar were 
used. 
 
Preparation of pomace extracts. Blackberry and Blueberry whole fruit were bought from local 
market and brought in lab. One liter water was heated up to 95˚C. A kilogram of blackberry or 
blueberry was treated with this water for 3 min and water was discarded. Mixture of 400 ml sterile 
water and 82 µl (a rate of 0.0827 ml/kg of berry) pectinase enzyme (Novozyme Corp., Bagsvaerd, 
Denmark) was added to treated berry and incubated at room temperature for 1 hour followed by 
vigorous blending. Juice portion was filtered out, stored at 4˚C and pomace was separated, dried 
at 40˚C in a HERATherm oven (Thermo Scientific) and stored in dark container at 4˚C.  
Ethanol (10%) in water was used as solvent for extraction. 2.5 g pomace was suspended in 
50 ml extraction solution and incubated overnight at 60˚C. After 24 hours, solid portion was 
separated using centrifugation and the supernatant was sterilized with 0.45 µm filter (AcroVac 
Filter Unit, Pall Life Sciences). The solvent was evaporated by vacuum freeze drying and it was 
resuspended in demonized water and adjusted the concentration. Total phenolic content was 
calculated as milligrams of gallic acid equivalent per milliliter of solution. 
 
Determination of total phenolic contents in pomace extracts. Total phenolic content in each extract 
was determined using the spectrophotometric method described by Singleton et al., 1999. Briefly, 





Ciocalteu reagents (MP; Cat #195186). After 5 min incubation, 300 µL 7.5 % Na¬2CO3 was added 
to the mixture and allowed to leave for another 2 hours at room temperature. The absorbance was 
determined with spectrophotometer (PerkinElmar, Lambda Bio) at λmax = 765 nm. All the 
samples were prepared in triplicate for each analysis and the mean value of absorbance was 
determined using calculation method. The similar procedure was applied using standard solutions 
of gallic acid and the standard calibration curve was constructed. To construct the calibration 
curve, 50 ml 10 mg/ml gallic acid stock solution was prepared and 0, 0.25, 0.5, 1.0, 1.5, 2.0, 2.5, 
3.0 mg/ml gallic acid solutions were formulated from the stock solution for individual points in 
the curve. The total phenolic content was expressed as gallic acid equivalent (GAE). 
 
Determination of minimum bactericidal concentration of pomace extracts against P. multocida. 
Minimum Inhibitory Concentration (MIC) was determined using broth micro-dilution method 
previously described by Nkanwen et al., (2009). The concentrations ranging from 0.0 mg/ml to 1.0 
mg/ml berry pomace extracts or 0% to 1% citrus oil in TSB were used. 10 µL bacterial suspensions 
containing approximately 5×105 cfu/ml was added to each of the well of 24-wells plate. Plates 
were incubated for 24 hours at 37˚C with or without shaking. MIC was recorded as the lowest 
concentration of blackberry and blueberry pomace extracts or citrus oil that prevented visible 
growth of P. multocida. Minimum Bactericidal Concentration (MBC) was determined by culturing 
the last well showing visible growth and the wells with no visible growth on a blood agar plate. 
The lowest concentration that showing a significant reduction (>3 logs, 99.9%) was considered as 
MBC.  
 
Determination of cell surface Hydrophobicity. The bacterial cells were grown in the absence (no 
treatment) and predetermined elevated concentrations (concentration which did not show growth 
inhibition in 1 hour) of blackberry/blueberry pomace extracts and citrus oil at 37˚C for 1 h. The 
cells were then centrifuged at 3,000 × g for 20 min. The supernatants were poured out and the cells 
were resuspended in 2 ml of phosphate buffer saline (PBS, pH 7.2) and optical density (OD) was 
adjusted (OD570) to 0.5 (Ht0). The bacterial suspensions were mixed with 1 ml of n-hexadecane 
and incubated for 5 min at room temperature. The aqueous phase was measured at 570 nm (Ht5) 
using a Multiskan microplate reader (Multiskan FC, Thermo Scientific). The hydrophobicity was 






Adhesion and invasiveness assay. Adherence and invasiveness assays were performed according 
to the method described previously (Biswas et al. 2000). Chicken fibroblast cell (DF1) and bovine 
mammary gland cell line (MacT) were used. Briefly, 100 µl bacterial suspension, containing CFU 
approximately 100 times higher than host (MacT or DF-1) cell number, was inoculated into 
triplicate wells of a 24-well tissue culture plate containing semi-confluent monolayers of MacT or 
DF1 cells. Infected monolayers were incubated for 1 h at 37³C under a 5% CO2 humidified 
atmosphere. The infected monolayers were washed five times with DMEM containing 1% Fetal 
Bovine Serum (FBS) and then reincubated for another 1 h in fresh DMEM containing 10% FBS 
and 250 µg/ml of gentamicin. The monolayers were washed three times with DMEM containing 
1% FBS and lysed with 0.1% Triton X-100 for 15 min. The suspensions were diluted and the 
numbers of viable bacterial cells were determined on LB agar plates. 
 
Growth Performance of S. Gallinarum, S. Pullorum and L. plantarum in the Presence of Pomace 
Extracts in Broth, Fecal Medium or Water. For growth inhibition assay in broth, S. Gallinarum 
and S. Pullorum were grown in LB broth and L. plantarum was grown in MRS broth, respectively, 
at 37 °C for 18 h. Then the cells were pelleted by centrifugation at 4000×g for 5 min and 
resuspended in phosphate buffered saline (PBS, pH 7.4). The optical density of the bacterial cell 
suspensions were adjusted to 0.1 at OD600 using spectrophotometer (PerkinElmer, MA). In the 
wells of 24-well culture plate, LB or MRS broth with 1.0-2.0 mg AGE/L blackberry or blueberry 
pomace extracts were prepared by adding required volume of extracts from the stock solutions. 
Autoclaved deionized water was added instead of the extracts in the control wells. Ten microliter 
bacterial suspension containing approximately 2×106 cfu was added to each of the well of 24-wells 
plates. Plates were incubated for various time points (24, 48 and 72 h) at 37˚C with shaking at 120 
rpm. After incubation, bacterial suspensions were made serial dilution in PBS and plated on LB 
agar for S. Gallinarum and S. Pullorum or MRS agar for L. plantarum to determine the colony 
forming units (cfu). 
For growth inhibition assay in fecal medium, chick feces was collected from poultry 
facility at the University of Maryland, College Park on campus farm. One gm feces was mixed 
with 5 mL deionized water to make a semisolid medium and sterilized by autoclaving. Various 





in 24-well culture plate. S. Gallinarum, S. Pullorum and L. plantarum inoculums were prepared as 
described above and inoculated into the fecal medium. Plates were incubated for 24, 48, and 72 h 
at 37˚C with shaking at 120 rpm followed by dilution in PBS and plating on agar medium for 
bacterial counts. 
For growth inhibition assay in water, similar protocol was applied. Various concentrations 
of blackberry or blueberry pomace extracts were added to autoclaved tap water and bacterial 
suspensions were added to each well. Plates were incubated for 15, 30, 45 and 60 min at 37˚C with 
shaking at 120 rpm followed by dilution in PBS and plating on agar medium for bacterial counts. 
 
Co-culture of pathogen and probiotic in fecal medium. Co-culture of S. Gallinarum and L. 
plantarum or S. Pullorum and L. plantarum was carried out in semisolid fecal medium in the 
presence or absence of blackberry or blueberry pomace extracts and compared to the growth of 
pathogens alone in the same medium. Pathogen and probiotic were attempted to mix equal volume 
of bacterial suspension (1:1) containing approximately 106 cfu/mL. Inocula were prepared in PBS 
as described above. Culture tube containing 980 μL semisolid fecal medium with various 
concentrations of blackberry or blueberry pomace extracts and 10 μL of each bacterial suspension 
was incubated for various time points (0, 24, 48, and 72 h) at 37 °C with shaking at 120 rpm. 
Viable cell counts were determined by the serial-dilution method using LB agar for S. Gallinarum 
and S. Pullorum, and MRS agar for L. plantarum, respectively. 
 
Determination of the effects of BPE on cultured host cells. Viability of cultured INT407, DF1, and 
HEK001 cells in the presence of various concentration of BPE was measured following the method 
described previously (Strober, 2001) with some modifications. In brief, 2×105 cells were 
inoculated into triplicate wells of a 24-well tissue culture plate containing serum-free 
Keratinocyte-SFM medium containing 5 ng/mL EGF (DMEM with 10% FBS for INT407 and 
DF1) incubated for 24 hr at 37˚C under 5% CO2. After incubation, cell monolayers were washed 
with Keratinocyte-SFM medium for three times and 1 mL of fresh Keratinocyte-SFM medium 
containing 5 ng/mL EGF and various concentrations of BPE (0, 50, 100, 200, 400, and 800 µg 
GAE/mL) were placed in triplicate wells. The plate was incubated for 2 hr at 37˚C under 5% CO2, 
the medium was decanted and viability assay was carried out with 0.4% Trypan Blue solution 





Store) and the images were processed in Microsoft Office Picture Manager (Version 2010). 
Treated HEK001 cell monolayers were also used to extract RNA with Quick-RNA MiniPrep Kit 
(Zymo Research) for quantitative RT-PCR assay. 
 
Statistical Analysis. All data were analyzed using the Statistical Analysis System software (SAS, 
Institute Inc., Cary, NC, USA). One-way analysis of variance (ANOVA) was used, followed by 





































Inhibition of P. multocida growth with berry pomace extracts. We found that pomace extracts from 
both blackberry and blueberry and citrus oil inhibited growth of P. multocida (Fig. 3.1). Paper 
disks containing 30 µg blackberry pomace phenolics and 22.5 µg blueberry pomace phenolics 
created clear zone of diameter 11 mm and 9.5 mm respectively (Fig. 3.1). These clear zones visibly 
indicated the growth inhibitory effect of blackberry and blueberry pomace extracts on P. 
multocida. In the same study, we also found that citrus essential oil showed inhibitory effect. 
 
Time dependent inhibitory effect of pomace extracts on P. multocida growth.  The Minimum 
Bactericidal Concentration (MBC) of blackberry pomace extract was 0.3 mg/ml; that was slightly 
lower than blueberry pomace extract. MBC for blueberry pomace extract was 0.4 mg/ml (Table 
3.1). In the same study, we observed that 0.05% of citrus oil inhibited the growth of P. multocida. 
We also found that both blueberry and blackberry pomace extracts, and citrus oil showed higher 
antimicrobial activity during incubation with continuous agitating condition. At that condition, 
MBC values for blackberry and blueberry pomace extracts, and citrus oil decreased to 0.05 mg/ml, 
0.25 mg/ml and 0.025% respectively. Based on these results, we decided the concentration for 
both pomace extracts for P. multocida growth inhibition and bactericidal effect assays at various 
time points. It was found that growth of P. multocida was inhibited with various concentrations of 
blackberry and blueberry pomace extracts in a time dependent manner. All three concentrations 
(0.3, 0.2 and 0.1 mg/ml for blackberry and 0.4, 0.3 and 0.2 mg/ml for blueberry) for both blueberry 
and blackberry pomace extracts showed inhibitory effect on P. multocida. We observed that all 
three concentrations (0.3, 0.2, 0.1 mg/ml) of blackberry pomace extract inhibited the growth of P. 
multocida completely after 24 hour time period whereas two higher concentrations of blueberry 
pomace extract (0.4 and 0.3 mg/ml) caused complete inhibition of P. multocida growth. The lowest 
concentration (0.2 mg/ml) of blueberry pomace extract used in this study inhibited the growth 
partially. This growth inhibition pattern suggested that an equilibrium condition where the rate of 
bacterial death and proliferation were almost equal (Fig. 3.2 B). We found that blackberry pomace 
extract showed delayed inhibitory effect on growth of P. multocida that became effective after 12 
h of incubation whereas blueberry pomace extract showed its inhibitory effect within few hours of 





growth inhibition. Higher concentrations (0.05 and 0.025%) reduced CFU/ml of P. multocida more 
than 7 logs in 24 hours (Fig. 3.2 C). Whereas, 0.0125% citrus oil showed inhibitory effect upto 4 
hours but did not affect P. multocida growth after 4 hours. 
 
Effect of berry pomace extracts on cell surface hydrophobicity of P. multocida. Cell surface 
hydrophobicity of P. multocida treated with berry pomace extracts and citrus oil were monitored. 
Bacterial cells were treated with 0.6 mg/ml blackberry and blueberry pomace extracts or 0.05% 
citrus oil for 1 hour. For control, deionized water was used instead of extracts. Treatments with 
both blackberry and blueberry pomace extracts caused significant increase in cell surface 
hydrophobicity but citrus oil did not show any effect. The control groups had a hydrophobicity 
value of around 7% and group treated with citrus oil had similar hydrophobicity that of control 
group. But blackberry treated group had 13% and blueberry treated group had approximately 21%. 
So, it is evident that, both of the treatments caused two to three folds increasing in cell surface 
hydrophobicity (Fig 3.3).  
 
Role of berry pomace extracts in Adhesion to and invasion into host cells by P. multocida. Both 
blueberry and blackberry pomace extracts reduced adhesion ability of P. multocida to both chicken 
fibroblast (DF1) and bovine mammary gland (MacT) cells. In DF1 cells, number of adhered 
bacteria decreased more than 50% in the presence of both blackberry and blueberry pomace 
extracts (Fig 3.4). Similarly, the reduction of adherence ability of P. multocida to MacT cells was 
observed. We found that both pomace extracts reduced the adherence ability of P. multocida to 
MacT cells more than 80% (Fig 3.4). Invasiveness of P. multocida in the presence of both 
blackberry and blueberry pomace extracts were also monitored. We found that both blackberry 
and blueberry berry pomace extracts reduced invasion ability of P. multocida into MacT cells by 
approximately 80%. In the same study, blueberry pomace extract reduced P. multocida invasion 
into DF1 cells by more than 30% whereas phenolics extract from blackberry pomace extract 
significantly increased (approximately 70%) the rate of  invasion of DF1 cells by P. multocida. 
For adherence and invasion assay, the role of citrus oil on P multocida was not carried out due to 
high lytic ability of the citrus oil. P. multocida cells treated with citrus oil were lysed with very 






Growth performance of probiotic and pathogens in broth. We found that bioactive extracts from 
both blackberry and blueberry pomace inhibited the growth of S. Gallinarum and S. Pullorum in 
LB broth significantly (Fig 3.5). Blackberry pomace extract, at a concentration of 2.0 mg AGE/L, 
reduced the growth of S. Gallinarum by approximately 5, 6 and 8 logs at 24, 48 and 72 h, 
respectively. The same concentration of blackberry pomace extract reduced the growth of S. 
Pullorum by 5 logs at 24 h and eliminated completely by 48 h of incubation. Blueberry pomace 
extract showed similar growth inhibition pattern. We observed that 2.0 mg AGE/L of blueberry 
pomace extract reduced the growth of both S. Gallinarum and S. Pullorum by more than 5 logs at 
24 h and completely eliminated by 48 h (Fig 3.5). However, 1.0 mg AGE/L of blackberry or 
blueberry pomace extract did not show any inhibitory effect on the growth of any of these 
pathogens in this study. On the other hand, 1.0 or 2.0 mg AGE/L blackberry or blueberry pomace 
extracts did not affect the growth of probiotic L. plantarum at 24, 48 and 72 h time points in broth 
(Fig 3.5).  We also observed that up to 4.0 mg AGE/L of blackberry or blueberry pomace bioactive 
extracts did not show any significant effect on the growth of L. plantarum in broth (data not 
shown).  
 
Growth performance of probiotic and pathogens in fecal medium in the presence of BPE. In Fig 
3.6, we showed the effect of blackberry or blueberry pomace bioactive extract on the growth of 
avian pathogenic Salmonella or probiotic L. plantarum in a simulated gut environmental 
conditional medium where poultry feces served as nutrient source. In this simulated gut conditional 
medium, blackberry pomace extract at a concentration of 2.0 mg AGE/L reduced the growth of S. 
Gallinarum and S. Pullorum by more than 4, 5 and 5 logs at 24, 48 and 72 h time points, 
respectively. We also found that the lower concentration of blackberry pomace extract (1 mg 
AGE/L) showed the inhibitory effect against these pathogens significantly. One mg AGE/L of 
blackberry pomace extract caused growth inhibition by more than 2 logs at each time points (24, 
48 and 72 h) for both S. Gallinarum and S. Pullorum. Blueberry pomace bioactive extract showed 
slightly different growth inhibition pattern compared to blackberry pomace extract in fecal 
medium. Two mg AGE/L blueberry pomace extract completely inhibited S. Pullorum within 24 h 
but 1 mg AGE/L concentration caused complete inhibition of this pathogen at 72 h (Fig 3.6 B). 
The growth of S. Gallinarum was reduced significantly by both 1.0 and 2.0 mg AGE/L blueberry 





time points tested whereas S. Gallinarum growth went to undetectable level in the presence of 2 
mg AGE/L of blueberry pomace extract at 24 h. However, S. Gallinarum cells revived at 48 and 
72 h in the presence of 2 mg AGE/L blueberry pomace extract. On the other hand, the growth of 
probiotic L. plantarum did not differ significantly from the control in the presence of various 
concentration of blackberry or blueberry pomace extracts at different time points (Fig 3.6 C). Yet, 
numerical but not significant growth stimulation of L. plantarum was observed at 72 h in the 
presence of both blackberry or blueberry pomace extracts, where 2.0 mg AGE/L showed slightly 
higher growth stimulation compared to 1.0 mg AGE/L for both extracts (Fig 3.6 C). 
 
Growth inhibition of S. Gallinarum and S. Pullorum in water. We observed that blackberry or 
blueberry pomace extract were able to completely inhibit avian pathogenic Salmonella within 1 h 
in autoclaved tap water (Fig 3.7). The log cfu of both S. Gallinarum and S. Pullorum remained 
stable in tap water over the period of 60 min in absence of berry pomace extracts. Blackberry and 
blueberry pomace extracts showed different effects in terms of amount of time required to inhibit 
the pathogens. S. Gallinarum was completely inhibited by 1.0 mg AGE/L of blueberry and 
blackberry pomace extracts at 45 and 60 min respectively in tap water. Both bioactive extracts of 
berry pomaces inhibited these poultry pathogens at a concentration of 2 mg AGE/L by 30 min 
completely, but blueberry pomace extract showed quick activity compared to blackberry pomace 
extracts. Blueberry pomace extract inhibited the growth of S. Gallinarum by more than 4 logs 
within 15 min, whereas blackberry pomace extract caused a reduction of just 0.5 logs at that time 
period (Fig 3.7 A). Growth of S. Pullorum was inhibited completely by 2.0 mg AGE/L blueberry 
and blackberry pomace extracts at 30 and 45 min, respectively. At the lower concentration (1 mg 
AGE/L), both extracts required 60 min to inhibit completely but inhibition pattern suggested that 
blueberry pomace extract inhibited S. Pullorum at a faster rate compared to blackberry pomace 
extract over the period of 60 min (Fig 3.7 B).  
 
Co-culture of L. plantarum and S. Gallinarum in the Presence of Berry Pomace Extracts. In Fig 
3.8, we showed the growth performance of S. Gallinarum and L. plantarum when co-cultured in 
semisolid fecal medium. L. plantarum reduced the growth of S. Gallinarum by approximately 1, 2 
and 2 logs at 24, 48 and 72 h, respectively in co-culture condition compared to S. Gallinarum 





extracts in co-culture, no detectible growth of S. Gallinarum was observed after 24 h (Fig 3.8 A). 
On the other hand, growth and survivability of L. plantarum remained unchanged regardless the 
growth condition, grown alone or co-cultured with S. Gallinarum in fecal medium. We observed 
that in the presence of 1 mg AGE/L blackberry pomace extract, the growth of L. plantarum in co-
culture with S. Gallinarurm increased significantly by ~0.5 log at 48 h. Both blackberry and 
blueberry pomace extracts numerically stimulated L. plantarum growth at 72 h compared to the 
control at the same time point (Fig 3.8 B). 
 
Co-culture of L. plantarum and S. Pullorum in the Presence of Berry Pomace Extracts. Growth 
performance of S. Pullorum in co-cultured with L. plantarum in fecal medium is shown in Fig 3.9. 
When co-cultured with L. plantarum in fecal medium, the growth of S. Pullorum was reduced by 
1, 2 and 3 logs at 24, 48 and 72 h, respectively compared to control at these time points. However, 
in the presence of 1 mg AGE/L blackberry or blueberry pomace extracts in co-culture of L. 
plantarum with S. Pullorum reduced to non-detectable level of S. Pullorum after 24 h (Fig 3.9 A). 
Growth pattern of L. plantarum was unaltered whether grown alone or in co-culture with S. 
Pullorum. But when 1 mg AGE/L blackberry or blueberry pomace extracts were present in the co-
culture medium, L. plantarum was stimulated significantly by 0.5-1.5 logs at 48 and 72 h compared 
to the control (Fig 3.9 B). 
 
Effect of BPE on host cell viability. Trypan blue exclusion assay indicated a dose dependent 
reduction in the viability of adherent host cells to the plastic surfaces (Fig 3.10).  The percentages 
of 96.06, 92.72, 92.42, 91.51, 90.61, and 87.88 of adherent HEK001 cells to the plastic surfaces 
were remained viable after 2 hr treatment with 0, 50, 100, 200, 400, and 800 µg GAE/mL of BPE, 
respectively (Fig. 3.10). Usually, HEK001 human cultured keratinocytes are large, epithelial, 
round, adherent cells growing as a confluent monolayer and after 2 hr exposure to the tested 
concentrations of BPE, neither substantial changes in cell morphology, nor any detachment from 
the surface were noticed microscopically. However, a slight dehydration was observed with the 
increasing concentrations of BPE. Investigation into the expression of HEK001 genes playing 
important roles in necrosis, apoptosis, and autophagy pathways indicated that treatment with BPE 
induced the expression of Bcl-2 (inhibitor to apoptosis and autophagy pathways) by ~ 2 while 





No significantly differential expression of host (HEK001) cells was observed in the other tested 
genes (TRAF2, Ripk1, Map1Lc3, Casp3, APAF1, BECN1, MLKL, Atg12, Cacp8, and Ripk3) 
tested. 
 
Anti-inflammatory effect of BPE on chicken macrophage cells (HD11). Infection of HD11 cell 
with C. jejuni did not cause any detectable alteration in the expression of inflammatory genes. We 
also infection the HD11 cell with Avian Pathogenic E. coli (APEC) which resulted in higher level 
of expression of inflammatory genes. However, in the presence of BPE, the expression of pro-


































Uses of antimicrobial compounds as feed supplement and/or veterinary drugs in animal infectious 
diseases treatment are important for safer and economical production of farm animals. Growing 
antimicrobial bacterial resistance pattern is also an emerging issue and there is an unsolved debate 
about the role of antimicrobial use in farm animal production. Currently, organic products are 
getting popularity and growing faster than ever but microbial safety of the products and production 
lost due to various animal diseases in the absence of antimicrobial are making them fragile. 
Considering these emerging issues, we aimed to find an alternative and natural organic 
antimicrobial compounds for production of both conventional and organic farm animals. 
For alternative antimicrobials from natural sources for organic animal production and 
replacing synthetic antimicrobial for conventional farming, in this study we extracted the bioactive 
compounds from the byproducts of berries using ethanol-water and tested its inhibitory effect on 
the common poultry and cattle pathogen, P. multocida. We also tested the citrus oil, a byproduct 
of orange juice company, in inhibition of P. multocida growth. All the antimicrobials used in this 
study, blackberry and blueberry pomaces extracts and citrus oil, inhibited the growth of P. 
multocida effectively. In previous studies, we found that blueberry and blackberry juice inhibited 
the growth of human enteric bacterial pathogens including Campylobacter jejuni, Salmonella 
enterica serovar Typhimurium, enterohemorrhagic E. coli and Listeria monocytogenes (Biswas et 
al 2012, Yung et al 2013). In this study, we showed that extracts from the byproducts of both 
blueberry and blackberry inhibited the poultry pathogen. Therefore, berry juices or its extracts 
could be potential antimicrobial for human food preservation or supplement whereas the cheap 
organic and consumer friendly byproducts of berries could be an alternative feed supplement for 
farm animal specifically poultry. We also observed that susceptibility to these bioactive 
compounds increased due to agitation, which indicates increased contact between phytochemicals 
and bacterial cell is important for inhibition. Lacombe et al., (2013) found that blueberry 
phytochemicals inhibit bacteria by disrupting bacterial cell wall. We hypothesize, citrus oil and 
berry pomace phytochemicals have affinity towards outer membrane component of P. multocida, 
hence agitation caused increased interaction of these phytochemicals to outer membrane 
components and ultimately increased inhibition was found. Further experiments are underway to 





In respect of required time for effectiveness, blueberry pomace extract inhibited P. 
multocida growth faster compared to blackberry. Though, a higher concentration of blueberry 
pomace extract was needed to inhibit similar degree of P. multocida growth compared to 
blackberry pomace extract. Compositional differences in bioactive phytochemicals present in these 
two extracts might be the main reason of different rate of P. multocida growth inhibition. 
Compared to both blackberry and blueberry pomace extracts, citrus oil showed faster growth 
inhibition, even 0.0125% reduced P. multocida growth upto 4 hours but growth inhibition waned 
after that time period, which indicates exhaustion of responsible bioactive compounds in citrus oil. 
Limonene, a volatile monoterpene, is the major component of citrus essential oil and shows 
bactericidal effect against pathogenic bacteria (Fisher et al., 2008; Espina et al., 2013). So our 
results indicated that evaporation of limonene caused reduced inhibitory effect over longer period 
time. 
We also checked physicochemical property of P. multocida after treatment with natural 
bioactive extracts. When the bacterial cells were treated with blackberry and blueberry pomace 
extracts, the physicochemical properties of P. multocida specifically cell surface hydrophobicity 
was increased significantly. Previously Arif et al., (1998) showed that inability to synthesize 
capsular material by P. multocida enhanced cell surface hydrophobicity which indicated a direct 
correlation between presence of capsule and cell surface hydrophobicity. As capsule is an 
important virulence factor of P. multocida (Harper et al., 2006) and play an important role in 
bacterial adherence to host cells (Al-haj et al., 2004). Increased hydrophobicity in the presence of 
berry pomace extracts indicated the capsule disruption. On the other hand, treatment with citrus 
oil did not alter cell surface hydrophobicity of P. multocida. 
In addition, we also observed that berry pomace extracts altered host cell-P. multocida 
interactions. Adherence to DF1 and MacT cells decreased significantly due to the pre-treatment of 
bacterial cells with pomace extracts. This decreased adherence provided further support in capsular 
disruption in the presence of pomace extracts.  In another study, Esslinger et al., (1994) have found 
decreased adhesion of P. multocida serotype A to HeLa cells due to treatment with hyaluronidase 
which acted against hyaluronic acid in capsule. Borrathybay et al., (2003) found the opposite, an 
increased adherence to chicken embryo fibroblast (CEF) due to treatment with hyaluronidase but 
decreased adherence after treatment with trypsin and hyaluronidase combined, indicating the 





as well as outer membrane proteins are important for P. multocida virulence. Decreased adherence 
in our study suggests, berry pomace extracts not only disrupts bacterial capsule but affects surface 
proteins also. P. multocida invasion into MacT cells also decreased due to treatment with berry 
pomace extract phenolics. Similar decrease in invasion was found in DF1 cells when treated with 
blueberry pomace extract but interestingly an increased invasion occurred due to treatment with 
blackberry pomace extract. Further study is necessary to explain this phenomenon. 
Maintaining the well-being of poultry health is always crucial to the producers in terms of 
productivity and product safety, irrespective of the rearing system adopted: MCLF or backyard, 
free-range pasture organic or conventional poultry farming. In addition, prognosis of disease and 
implementation of appropriate treatment strategies are important to ensure safer and cost effective 
production of poultry. Further, increased antimicrobial resistance among zoonotic pathogens have 
raised a multifaceted debate on whether nontherapeutic use of antibiotics in farm animal/livestock 
production should be endured any longer. Due to vast popularity of organic products among 
consumers, sustainable organic agricultural systems are now gaining increased attention among 
farmers. However, microbiological safety of organic products and production loss followed by 
economic instability due to various animal diseases in the absence of antibiotics are making 
organic farming practice an unprofitable enterprise. Considering these emerging issues, we 
focused on finding alternative and natural bioactive compounds to apply in both conventional and 
organic farming systems that will potentially replace antibiotics and chemical antimicrobials. 
 In this study, we used bioactive antimicrobial components extracted from byproducts of 
blackberry or blueberry called pomace and tested their inhibitory effect on avian pathogenic 
Salmonella strains such as S. Gallinarum and S. Pullorum. We also evaluated the efficacy of these 
pomace extracts to alter the growth dynamics of probiotic or modulate the growth of these poultry 
pathogens. We found that blackberry and blueberry pomace extracts inhibited the growth of S. 
Gallinarum and S. Pullorum in broth. In our previous studies, we also found that these extracts 
inhibited the growth of human enteric bacterial pathogens including Campylobacter jejuni, 
Salmonella enterica serovar Typhimurium, enterohemorrhagic E. coli and Listeria monocytogenes 
and poultry pathogen Pasteurella multocida (Biswas et al., 2012; Yang et al., 2014; Salaheen et 
al., 2014a; Salaheen et al., 2014b). Therefore, these bioactive compounds extracted from cheap, 
organic and consumer friendly byproducts of berry juice industry could act as natural feed 





Fecal materials make up a major portion of cecum content in poultry and most of the gut 
bacteria come in close contact to feces during their life cycle. As a result, fecal medium can be 
considered as a simulated poultry gut composite and bacterial behavior in fecal medium should 
partly correlate with in vivo situation. So we were interested to investigate the effects of bioactive 
components extracted from blackberry and blueberry pomace extracts on the growth of avian 
pathogenic Salmonella and probiotic L. plantarum in fecal medium. However, the quality and 
composition of fecal medium varies depending on the poultry diet, hence it might provide variable 
results. In this experiment, we found that fecal medium served as a good source of nutrient for the 
growth of both the pathogens and probiotic. In the presence of 1.0 mg AGE/L blackberry or 
blueberry pomace extracts, the growth of S. Gallinarum or S. Pullorum was reduced significantly 
in fecal medium whereas no such reduction was found in broth which suggested that these 
pathogens were more vulnerable in the semisolid fecal medium compared to broth. On the other 
hand, numerical increase on the growth of L. plantarum at 72 h time point was observed in the 
presence of blackberry or blueberry pomace extract in fecal medium but not in broth. This result 
suggested that, L. plantarum was able to switch its preference for source of nutrient and utilized 
some portions of the berry extract as nutrient in fecal medium but due to high nutritious condition 
in broth, this phenomenon was not observed while grown in broth. 
S. Gallinarum and S. Pullorum are able to transmit and colonize in poultry gut via both 
vertical and horizontal route (Berchieri et al., 2011; Olasupo et al., 2003; Prakash, 2006). Fecal-
oral route plays important role in horizontal transfer because pathogens remain viable in feces and 
water for many days. We found that, in the presence of blackberry or blueberry pomace extracts 
in water both S. Gallinarum and S. Pullorum were completely inhibited within 1 h. This supports 
the hypothesis that bioactive berry extracts will be able to reduce horizontal transfer of these 
pathogens when used as water supplement. Blueberry pomace extract inhibited S. Gallinarum and 
S. Pullorum growth quicker compared to blackberry in water. Difference in bioactive 
phytochemical profile of these two extracts might be the main reason of dissimilar rates of growth 
inhibition.  
Previous studies have reported that Lactobacillus can inhibit the growth of pathogens in 
co-culture condition (Williams, 1981; Soria et al., 2013; Servin, 2004). We also found that L. 
plantarum reduced the growth of S. Gallinarum and S. Pullorum when co-cultured in fecal 





inhibition of pathogens was more drastic when co-cultured with L. plantarum which suggested a 
synergistic relationship between the probiotic and berry extract. Berry extracts are good source of 
anthocyanin, hydroxycinnamic acid, hydroxybenzoic acid, polymeric tannins and other 
polyphenols (Puupponen-Pimiä et al., 2005; Hütt et al., 2006). Bioconversion of phenolic acids 
and anthocyanin by Lactobacillus have been reported (Salaheen et al., 2014c; Herrmann 1989). 
Though, metabolic pathways of Lactobacillus to utilize phenolic compounds have not been 
unearthed yet, it has been shown that bioconversion of phenolic compounds of some food caused 
an increase in their antioxidant activity (Rodríguez et al., 2008). We hypothesize that, partial 
degradation of berry pomace phenolics by L. plantarum increased bioavailability and antimicrobial 





1. BPE inhibited the growth of P. multocida, S. Gallinarum, and S. Pullorum in vitro.  
2. BPE stimulated the growth of probiotic Lactobacillus in fecal medium and provided 
selective bias towards probiotics when co-cultured with pathogenic Salmonella. 
3. Anti-inflammatory property of BPE reduced the expression of pro-inflammatory cytokines 
in chicken macrophage HD11 after infection with Avian Pathogenic E. coli.  
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Blackberry 0.3 mg/ml 0.05 mg/ml 
Blueberry 0.4 mg/ml 0.25 mg/ml 



























Fig. 3.1. Growth inhibition of P. multocida with blackberry (B) and blueberry (C) pomace extracts, 




























Fig. 3.2. Time dependent growth pattern of P. multocida in presence of various concentrations of 
































































Fig. 3.3. Cell surface hydrophobicity of P. multocida treated with blackberry or blueberry pomace 














































Fig. 3.4. Adhesion (A and C) and invasiveness (B and D) of P. multocida to DF1 and MacT cells 
respectively in presence of blackberry and blueberry pomace extracts. Bars containing * are 




































































































Fig 3.5. Growth performance of S. Gallinarum (A), S. Pullorum (B) and L. plantarum (C) in 
broth supplemented with 1.0 or 2.0 mg AGE/L of blackberry (Blk) and blueberry (Blb) pomace 
















































































Fig 3.6 Growth performance of S. Gallinarum (A), S. Pullorum (B) and L. plantarum (C) in fecal 
medium supplemented with 1.0 or 2.0 mg AGE/L of blackberry (Blk) and blueberry (Blb) 




























































































Fig 3.7. Inhibition of S. Gallinarum (A) and S. Pullorum (B) in deionized water supplemented 
with 1.0 or 2.0 mg AGE/L of blackberry (Blk) and blueberry (Blb) pomace extracts. Means from 



































































Fig 3.8. Growth performance of S. Gallinarum (A), and L. plantarum (B), when co-cultured in 
fecal medium supplemented with 1.0 mg AGE/L of blackberry (Blk) or blueberry (Blb) pomace 


































































Fig 3.9. Growth performance of S. Pullorum (A), and L. plantarum (B), when co-cultured in 
fecal medium supplemented with 1.0 mg AGE/L of blackberry (Blk) or blueberry (Blb) pomace 






































































Fig 3.10. Cytotoxicity of BPE on host cell-lines: INT407, DF1, and HEK001using microscopic 
and Trypan Blue methods. A, survival rate of INT407 and DF1 cells; B, HEK001 cell survival 
rate at various concentrations of BPE; C, visualization of cell morphology in the presence of 
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Fig 3.11. Anti-inflammatory effect of BPE on chicken macrophage cells (HD11) using qRT-
PCR. A, infection with C. jejuni in presence or absence of BPE; B, infection with Avian 















































Chapter 4: Role of berry pomace extracts on Campylobacter jejuni 
colonization in poultry gut. 
Introduction 
Campylobacter jejuni, a major foodborne enteric pathogen, is among the leading causative agents 
of acute gastroenteritis in the world. According to the Centers for Disease Control and Prevention 
(CDC), C. jejuni causes one million illnesses, 19,000 hospitalizations and 76 deaths per annum in 
the US (Scallan et al., 2011). Raw and undercooked poultry and poultry products are considered 
one of the major sources of campylobacteriosis (Mughini-Gras and van Pelt, 2014). C. jejuni along 
with other species of Campylobacter colonize in the poultry gut as normal flora. The ability of C. 
jejuni to adhere to host intestinal epithelial cells plays a primary role in the enteropathogenesis, 
multiplication and colonization. Therefore, the adherence phase can be considered as a critical 
control point in early intervention strategies to prevent the colonization of C. jejuni in host gut. 
Important physicochemical and mechanical properties, i.e., auto-aggregation, hydrophobicity, 
cellular motility are associated with the adhesion ability of bacterial pathogens to the host epithelial 
cells (Parker et al., 2001; Saran et al., 2012), and these properties eventually lead to bacterial 
colonization followed by invasion. These phases of activities should be considered in the quest of 
intervention strategies to reduce the colonization of C. jejuni in poultry gut with the ultimate goal 
to prevent C. jejuni cross-contamination in poultry products and reduce the C. jejuni associated 
foodborne infections in humans.  
 Commonly used control measures against the colonization of C. jejuni in poultry gut 
include the use of antibiotics, synbiotics, and bacteriophages in feed and water. However, 
development of antibiotic resistance, low efficacy of synbiotics, and high strain specificity of 
bacteriophages render these control measures tricky. In response to increased public health concern 
on antibiotic resistance, the U.S. Food and Drug Administration has announced to gradually 
withdraw non-therapeutic use of antibiotics from farm animal production (Kuehn, 2014). 
Consequently, the search for alternative natural and green antimicrobials is now more essential 
than ever. Bioactive phenolics from berries, especially blackberry (Rubus fruticosus) and blueberry 
(Vaccinium Corymbosum) pomace as feed or water supplement to reduce pre-harvest level of C. 
jejuni contamination in farm animals, specifically poultry, might be a feasible alternative. 





bacterial pathogens have been extensively studied (Biswas et al., 2012; Puupponen-Pimiä et al., 
2005; Salaheen et al., 2014a; Yang et al., 2014). In our previous studies, we showed the bactericidal 
effect of phenolic extracts from berry fruits on Campylobacter jejuni, Salmonella Gallinarum, 
Salmonella Pullorum, and Pasteurella multocida (Salaheen et al., 2014a, 2014b; Salaheen et al., 
2015). Proposed mechanism of pathogen inhibition of these phenolics include damage of bacterial 
cell membrane (Lacombe et al., 2013), inhibition of extracellular microbial enzymes (Scalbert, 
1991), distortion of microbial metabolism, and deprivation of substrates mandatory for microbial 
cell proliferation and pathogenicity (Puupponen-Pimiä et al., 2004). Importantly, synergisms 
among various phenolic derivatives act indiscriminately against benign and pathogenic bacteria.  
Therefore, in this study we aimed to evaluate the effect of these extracts on the colonization 
of C. jejuni in chick cecum. Findings from this study will provide significant insight into the 
alternative preventive and therapeutic antimicrobial regime to reduce C. jejuni infection by 
developing a new, effective, and green antimicrobial against bacterial infections.  
Material and Methods 
Preparation of pomace extracts and HPLC-tandem mass spectrometry (LC-MS/MS) analysis. 
Extracts were prepared according to the protocol previously described (Salaheen et al., 2014a). 
Total phenolic content in each extract was determined using spectrophotometric method (Singleton 
et al., 1999). Total phenolic content was expressed as Gallic Acid Equivalent (GAE). The pH of 
the crude extracts were 4.5-5 and pH varied depending on the treatment concentration. A phenolic 
screen was accomplished using HPLC-MS (Peng et al., 2014).  Sample injections were 5 µL and 
separations were performed on an Agilent 1100 system, coupled to an Agilent MSD-TOF (time-
of-flight) mass spectrometer.   Reversed-phase liquid chromatography was used to separate the 
samples.  A Waters Atlantis T3 column (3 µm, 150 x 2.1 mm i.d.) was used.  A binary mobile 
phase consisting of solvent systems A and B was used in gradient elution where A was 0.1% formic 
acid (v/v) in ddH2O and B was 0.1% formic acid (v/v) in acetonitrile.  Mobile phase flow rate was 
0.3 mL/min.  The linear gradient was as follows:  time 0 – 1 minute, 0% B; time 40 minutes, 90% 
B; time 41 minutes, 90% B; time 42 minutes, 0% B; time 52 minutes, 0% B.  Following the 
separation, the column effluent was introduced by electrospray ionization (ESI) into the MSD-
TOF.  Samples were assayed, using positive mode ESI.  Source parameters were:  gas temperature 





acquired with a mass range of 75 - 1000 m/z.  Accurate mass accuracy was guaranteed by the 
continuous infusion of Agilent Reference Mass Solution (G1969-85001). Individual 
chromatographic peaks were identified using Agilent’s Mass Hunter Qualitative Analysis software 
(v. B.06).  Compounds were identified using Agilent’s Mass Profiler Professional software (v. 
13.1).  Peaks in duplicate injections were aligned to account for instrumental drifts in retention 
time and mass.  Compounds were retained only if they appeared in both duplicate samples.  
Compounds were annotated by querying Agilent’s METLIN human metabolite database, with a 
mass error criteria of < 5 ppm.  
 
Insertion of genetic marker Kanamycin (Km) gene in C. jejuni RM1221. Kanamycin resistance 
cassette was infused to C. jejuni RM 1221 genome to be used as marked strain according to the 
protocol depicted in the figure. In 
brief, the AB and CD PCR 
products were fused together to 
generate AD product deleting the 
internal segment (dotted line) by 
a third PCR using A and D 
primers. By sequential cloning 
steps, Km gene was inserted in 
the middle of AD followed by 
final cloning into a suicide vector 
pDS132 and the resulting 
recombinant suicide plasmid was 
introduced into the wild-type C. 
jejuni RM1221 strain. After 
homologous recombination, 
desired mutant having Km 
insertion in place of cdtABC 






recognition sequences. The new strain was named as C. jejuni RM-Km. 
  
Natural colonization of chicks with Campylobacter. Natural colonization of Campylobacter in 
chick model provided with various concentrations of BPE was determined in triplicate trials. In 
each trial, 100 1-day-old Cobb-500 broiler chicks were obtained from Longenecker’s Hatchery 
Inc, PA. Guidelines recommended in the Institutional Animal Care and Use Committee (IACUC, 
protocol number R-16-33) were followed for chick husbandry and were provided with 
commercially available crumbles (Purina Animal Nutrition, MO) with no antibiotic 
supplementation. In trial 1, chicks were assigned to 4 groups provided with only tap water or tap 
water with 0.1, 0.5, and 1.0 g AGE/L of BPE. In the following 2 trials, chicks were assigned into 
4 groups of 25 chicks each in floor pans using a Completely Randomized Design consisting a 
negative control, a positive control, and two treatment groups. Negative control group A was 
provided with only tap water, positive control group B: tap water with AGP (a combination of 
Oxytetracycline 1 µg/mL, Erythromycin 2 µg/mL, Tylosin 2 µg/mL, Bacitracin 4 µg/mL and 
Neomycin sulfate 32 µg/mL), treatment group C: tap water with 0.1 g GAE/L of BPE. Treatment 
group D was provided with tap water with 0.1 g GAE/L of BPE and the treatment concentration 
was increased to 1 g GAE/L during last 72 h before euthanasia. This way the chicks were reared 
for 6 weeks. After three weeks, five chicks from each group were euthanized to check the natural 
colonization level of Campylobacter in chick cecum. After six weeks, all the birds were euthanized 
and ceca were separated. To check the Campylobacter colonization, approximately 200 g of cecum 
content was homogenized in one mL PBS, serially diluted and plated on Karmali Campylobacter 
agar for enumeration. Three representative presumptive isolates from each group were tested with 
Campylobacter specific PCR according to the protocol described by Salaheen et al., (2016). 
Cecum from each bird was considered an experimental unit for statistical analysis. The number of 
birds colonized by Campylobacter was compared using Fisher’s exact test. Differences in the level 
of colonization (CFUs/g cecum content) were compared by first ranking the data and performing 
one-way analysis of variance (ANOVA) on the ranked data. Comparison of mean ranks was 
performed using Tukey’s test. 
 
Infection of chicks with C. jejuni RM-KM. A total of 120 chicks were used for 2 trials. Chicks were 





berry pomace extracts. The chicks were randomly assigned to control and test groups (20 chicks 
per group). Four cages of the unit were assigned to each group, so a total of 5 chicks per cage. 
Stocking density has been calculated and conforms the IACUC guideline. A Completely 
Randomized Design (CRD) were employed for this purpose. The reason behind using similar 
number of chicks in the control group was that, in this experiment the control itself (regular water) 
served as a treatment. 
C. jejuni RM-Km was cultured on Blood Agar plates for 24 h under microaerophilic 
condition and transferred to saline to a concentration of 109 cfu/mL.100 uL of this suspension was 
fed to day-old chicks with oral gavage. For this purpose, chicks were held gently (one at a time). 
Animal feeding needle attached to plastic syringe was used. 100 uL C. jejuni RM-KM suspension 
was taken into the syringes, and this suspension was fed to one chick using the feeding needle. 
Chicks were checked for any injury related to the gavage procedure and transferred back to their 
respective cages. Chicks were kept in close inspection for atleast two days for any abnormalities 
in their eating or drinking behaviors. The chicks were provided tap water to group A, 1.0 mg 
AGE/L BPE in tap water to group B. For group C, chicks were provided with 0.1 mg AGE/L BPE 
throughout, except last 72 h before euthanization, the treatment concentration were increased to 
1.0 mg AGE/L BPE in tap water. This way the chicks were reared for 3 weeks, fed with chicken 
starter diet (mesh) without growth promoters or synthetic chemicals. Water were provided in 
gravity feed water containers. After week 1, 8 chicks from each group were euthanized. After week 
2, 8 chicks from each group were euthanized, and similarly, after week 3, rest of the chicks were 
euthanized. 
 
Statistical Analysis. Quantitative RT-PCR data will be analyzed using the Statistical Analysis 
System software (SAS, Institute Inc., Cary, NC, USA). One-way analysis of variance (ANOVA) 









Development of kanamycin cassette marked C. jejuni. We developmed a C. jejuni mutant 
possessing kanamycin resistance cassette incorporated in the genome for easy detection of the 
marked C. jejuni strain in chicken ceca. From the PCR band sizes indicated in Fig 4.1, it was clear 
that the clone contained right size of band representing kanamycin resistance cassette. We found 
three clones and used one for the further studies. The product size of the sequence of interest in 
wild type C. jejuni RM1221 was 3204 base paires, whereas the mutants should have been 2649 
base paires and this phenomenon is evident in Fig. 1.  
Phenotypic characteristics of the newly developed mutant indicated a similar growth 
pattern of the mutant compared to the wild type C. jejuni strain. We prepared the glycerol stocks 
of the mutants and stored at -80˚C. The efficacy of the mutants was tested by multiple subculturing 
in kanamycin free medium to check whether the mutants are loosing the kanamycin resistance 
cassette in the absence of selective pressure of certain concentrations of kanamycin. We observed 
that the mutants showed resistance to 100 µL/mL of kanamycin in broth even after 14 subcures in 
kanamycin-free broth medium. 
 
Natural colonization of chicks with Campylobacter. We tested the natural colonization of chicks 
with Campylobacter when provided with 0-1.0 g GAE/L of BPE as water supplement. We checked 
the natural colonization level by euthanizing five chicks from each of the four groups after three 
weeks. 100% of the euthanized chicks were naturally colonized with Campylobacter after three 
weeks in groups A, B, and C but 20% chicks in group D, given 0-1.0 g GAE/L of BPE as water 
supplement (Fig. 4.2). After six weeks, all the chicks were euthanized. The observed median level 
of colonization of the cecum contents by Campylobacter was five logs lower (p < 0.001) in 
presence of 1.0 g AGE/L of BPE compared to the chicks provided with only tap water. However, 
this high concentration caused an approximately 4% reduction in the chicken weight, though this 
value was not statistically significant. 
Due to this issue, we redesigned our experiment in the second and third trials. Instead of 
using 1 g GAE/L of BPE for whole 6 weeks period, we suppmenented the water with 0.1 g AGE/L 
of BPE for 39 days and for the last 3 days before euthanasia, we increased the treatment 





ceca. We observed, addition of 1 g GAE/L of BPE in water resulted a reduction of 2 logs in the 
number of Campylobacter colonized in the ceca. But no difference was observed when chickens 
were provided with 0.1 g GAE/L of BPE in the context of Campylobacter colonization in chicken 
ceca (Fig 4.3). 
 
Colonization of chicks with C. jejuni RM-KM. We infected day-old chicks with C. jejuni RM-Km 
and tested the colonization of chicks with mutant when provided with 0-1.0 g GAE/L of BPE as 
water supplement. Important to note that, in the experiment, chicks were reared in ventilated cages 
and gorwed upto 3 weeks. 100% of the euthanized chicks were naturally colonized with 
Campylobacter after one, two and three weeks in groups all the chicks (Fig. 4.4). After one week, 
8 chicks per group, after two weeks, 8 chicks per group, and after three weeks, 4 chicks per group 
were euthanized by cervical dislocation followed by decapitation. The observed median level of 
colonization of the cecum contents by Campylobacter was one log lower (p < 0.001) in presence 
of 1.0 g GAE/ L of BPE compared to the chicks provided with only tap water. Whereas, 
supplementation of 1.0 g GAE/L of BPE during the last 3 days before euthanasia resulted in 0.5 


















As berries specifically blackberry and blueberry as well as their pomaces are rich sources of 
phenolic compounds (Nohynek et al., 2006; Puupponen-Pimiä et al., 2004), and berry pomaces are 
abundant from the fruit juice industry in the US, the berry pomaces are a plausible and economic 
raw material for extraction of phenolic extracts and can be used in biomedical sector as well as 
farm animal production. HPLC/high mass accuracy TOF mass spectrometry analysis indicated that 
major phenolic compounds in both Blk and Blb pomaces included, flavan, flavanone, flavones, 
glucuronides, glucosides, quinolones, catechol, coumarin, phenols, luteolines, tannins, quercetin, 
chlorogenic acid, ellagic acid, gallic acid, and xanthoxic acid. This finding remain constant with 
previous literatures which also reported the presence of these compounds in berries (Mertz et al., 
2007; Nohynek et al., 2006; Puupponen-Pimiä et al., 2004) though structural and categorical 
diversity can be noticed among the phenolic compounds. Factors influencing this diversity include, 
but are not limited to, species and genetic makeup of berries, agricultural practices, season of 
harvest, irrigation, soil constituent, types of fertilizers used, processing during juice extraction, and 
storage of the pomaces. Literature survey demonstrates that crude extracts show better 
antimicrobial efficacy compared to individual compounds (Bajpai et al., 2012) and we also found 
that combined mixture of commercially available quercetin, gallic acid, teichoic acid, catechol, 
and coumaric acid had lower MIC value on Salmonella and Campylobacter compared to each of 
the individual compounds (data not shown). Due to the reported synergism among various types 
of phenolic compounds, the use of crude extract instead of purified compounds is justifiable.  
After a series of studies on the effect of phenolic extracts from berry pomaces on 
pathogenic bacteria and probiotics (Salaheen et al., 2014a; Salaheen et al., 2014b; Yang et al., 
2014; Salaheen et al., 2015), in this study, we present the bactericidal effect of these extracts 
against pathogenesis and colonization of Campylobacter in chicken gut. However, this does do not 
deny the bacteriostatic nature that was noticed from the use of sublethal concentrations of these 
phenolic extracts that showed growth inhibition after 24 h but revealed reduced or no effect after 
longer period of exposure. This finding agrees with Puupponen-Pimiä et al., (2004) who also 
reported that raspberry and cloudberry phenolic extracts inhibited bacterial growth at the beginning 





inhibition of Campylobacter did not solely depend on pH. Depending on the concentration of berry 
pomace extracts, pH of the solution ranged from 4.5 to 6.5.  
Attachment is the prerequisite for Campylobacter colonization on intestinal epithelial cells 
followed by invasiveness, which are considered to be important virulence properties. Association 
of Campylobacter to cultured host cells, e.g., intestinal epithelial INT407, chick macrophage 
HD11, and chick fibroblast DF1 were altered; decreased association to INT407, increased 
association to HD11, and association remained unchanged in DF1 cells, after treatment with 
sublethal concentration of berry pomace extracts. Altered OM protein profile in Campylobacter 
can be a probable cause of increased associated bacterial number to HD11 cells. Hydrophobicity 
and surface charge of bacterial cells play an important role in the adhesion process as demonstrated 
previously (Oliveira et al., 2007). In the present case, the extent of adhesion seems to be directly 
related with cell surface hydrophobicity of Campylobacter. Unlike association, treatment with 
sublethal concentration of berry pomace extract significantly reduced Campylobacter invasion into 
all the host cell types. Alteration of mechanical and physicochemical properties (decreased auto-
aggregation and motility) may have impact on the reduction of invasiveness in Campylobacter 
which is supported by previous studies who showed positive correlation between bacterial motility 
and invasiveness into host cells (Golden, 2002; Salaheen et al., 2014a).  
In this study, we found that 0.5-1.0 g GAE/L of berry pomace extract significantly reduced 
the natural colonization of Campylobacter in chick cecum. This phenomenon can be explained by 
previous report from Clifford (2004), who documented that dietary phenolics are poorly absorbed 
in the small intestine and 90-95% accumulated in colon resulting high abundance of bioactive 
phenolic compounds to be interacted with resident bacteria. However, the inhibition of 













1. 1.0 g GAE/L of BPE reduced natural colonization of Campylobacter in chicken ceca by 5 
logs at 6 weeks of age in floor pans. 
2. 1.0 g GAE/L of BPE reduced Campylobacter colonization by 1 log upto 3 weeks of age 
while grown in isolated cageing system. 
3. Treatment with 1.0 g GAE/L of BPE for only 72 h before euthanasia resulted in 2 logs 
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Fig. 4.2. Effect of various concentrations of berry pomace extracts on Campylobacter 


























































Fig. 4.3. Effect of berry pomace extracts compared to AGPs on the colonization of C. jejuni in 
broiler gut. Groups were assigned in the following manner; broilers from group A (negative 
control): only tap water, group B (positive control): tap water with AGP, group C: tap water with 
0.1 g GAE/L of BPE, and group D: tap water with 0.1 g GAE/L of BPE for 39 days and 1.0 g 
GAE/L of BPE for last 3 days before euthanasia. 
 
 



































































Fig. 4.4. Effect of BPE on the colonization of C. jejuni RM-KM in chicken ceca. Panels A and B 































































Chapter 5: Berry pomace extracts on poultry growth promotion through 
modulation of gut microbiome and long term consequences. 
Introduction 
The discovery of antibiotics in the early 20th century followed by their economization due to large 
scale production during World War II for controlling human infections, have revolutionized 
agricultural animal, specifically poultry production in the post war era. Animal agricultural use 
accounts for more than half of the antibiotics produced in the United States (Lipsitch et al., 2002). 
However, environmental and public health risks associated with the emergence of antibiotic 
resistance in zoonotic bacterial pathogens through natural selection, due to therapeutic and/or non-
therapeutic use of antibiotics i.e., Antibiotic Growth Promoters (AGPs) for farm animal 
production, have led the policymakers from worldwide to adopt stringent precautionary 
measurements. This included the ban of AGP in Sweden starting 1986 followed by a series of 
events to an EU-wide ban in effect on January 1, 2006 (http://europa.eu/rapid/press-release_IP-
05-1687_en.htm). Recently, the US FDA Center for Veterinary Medicine recommended for 
judicious use of medically important antibiotics in feed based on key reports and scientific 
literature describing the impacts of AGP on development and transfer of antibiotic resistance traits 
among intestinal microbiota to the environment and humans through cross-contamination (FDA, 
2012, Kleun, 2014). In addition, USDA established the National Organic Program which include 
organic poultry production that focuses on poultry health, good environmental practices, and 
production quality without the use of antibiotics as mandated by the USDA. All these precautions 
as well as organic poultry production system, might help to mitigate the emergence of antibiotic 
resistance in pathogens in the long run but reduced growth rate in poultry will definitely jeopardize 
food security. These emerging issues to both conventional and organic poultry industries warrant 
the need for alternative approaches to render the consequences following AGP removal from feed. 
By-products (pomaces) from berry fruits including blueberry (Vaccinium corymbosum) 
and blackberry (Rubus fruticosus), are major sources of phenolics and have roles in host health 
improvement through anti-inflammatory, antimicrobial, anti-carcinogenic, anti-oxidant, 





al., 2011; Salaheen et al., 2014; Joseph et al., 2014). Dietary supplementation of plant phenolic 
extracts have been demonstrated to enhance growth performance in broilers but their mechanism 
of action is far from being elucidated (Herna´ndez et al., 2004). Recent observational and 
epidemiological studies indicated differential microbial diversity in conventional broilers to their 
organic counterparts (Torok et al., 2011; Singh et al., 2013; Mancabelli et al., 2016). Neutral effect 
of AGP on germ free animals indicated the importance of AGP-dependent gut microbiota 
modulation on growth promotion in animals (Coates et al., 1963). Turnbaugh et al., (2006) 
revealed the association of two dominant bacterial divisions, the Bacteroidetes and the Firmicutes 
to weight gain which was supported by other research groups (Gong et al., 2008; Singh et al., 2013; 
Mancabelli et al., 2016). Gong et al., (2008) reported an increased abundance of Lactobacillus 
spp., Clostridiales and Enterobacteriaceae and later, correlation among Firmicutes to Bacteroidetes 
(F/B) ratio with increased weight gain and antibiotic treatment was reported (Singh et al., 2013). 
These findings inspired a comparative view on the effect of AGP versus phenolics on the 
modulation of broiler gut microbiota, resistome profile, functional enzymes involved in digestion, 
phage induction and overall potential mechanism behind the improved growth performance.  
In this study, we determined the composition of phenolic extracts from blueberry and 
blackberry and evaluated their roles as an alternative intervention to promote the growth of poultry 
by modulating gut microbiota. We also aimed to study the resistome profile in poultry ceca which 
will provide important insights into the applicability of these extracts to replace AGP. 
Material and Methods 
Preparation of pomace extracts and HPLC-tandem mass spectrometry (LC-MS/MS) analysis. 
Blueberry and blackberry pomace extracts were prepared according to the protocol previously 
described using commercial pomaces (powder form) that were kindly donated by Milne Fruit 
Products Inc., WA and stored at 4°C (Salaheen et al., 2014; Salaheen et al., 2016). Berry pomace 
extract (BPE) was comprised of blackberry and blueberry pomace extracts at 1:1 v/v ratio. Total 
phenolic content in each extract was determined spectrophotometricly (Singleton et al., 1999) and 
expressed as Gallic Acid Equivalent (GAE). The pH of the crude extracts varied from 3.5 to 4.5. 
Screening of phenolic compounds was performed using the HPLC-MS method described 
previously by Peng et al. (2015).  Briefly, sample injections were 5 µL and separations were 





TOF (time-of-flight) mass spectrometer.   Reversed-phase liquid chromatography was used to 
separate the samples with a Waters Atlantis T3 column (3 µm, 150 x 2.1 mm i.d.) (Waters, MA). 
A binary mobile phase consisting of solvent systems A and B was used in gradient elution where 
A was 0.1% formic acid (v/v) in ddH2O and B was 0.1% formic acid (v/v) in acetonitrile.  The 
mobile phase flow rate was 0.3 mL/min.  The linear gradient was as follows:  time 0 – 1 minute, 
0% B; time 40 minutes, 90% B; time 41 minutes, 90% B; time 42 minutes, 0% B; time 52 minutes, 
0% B.  Following the separation, the column effluent was introduced by electrospray ionization 
(ESI) into the MSD-TOF.  In this study, samples were assayed using negative mode ESI.  Source 
parameters were: gas temperature = 350˚C, gas flow = 9 L/min, nebulizer = 35 psi, fragmentor = 
125 V, and capillary voltage = 3500 V.  Data were acquired with a mass range of 75 - 1000 m/z.  
Mass accuracy was guaranteed by the continuous infusion of Agilent Reference Mass Solution 
(G1969-85001). Individual chromatographic peaks were identified using Agilent’s Mass Hunter 
Qualitative Analysis software (v. B.06).  Compounds were identified using Agilent’s Mass Profiler 
Professional software (v. 13.1).  Peaks in duplicate injections were aligned to account for 
instrumental drifts in retention time and mass.  Compounds were retained only if they appeared in 
both duplicate samples.  Compounds were annotated by querying Agilent’s METLIN human 
metabolite database, with a mass error criteria of < 5 ppm.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
 
Diet regimens and weight gain in chickens. Diet supplement experiments in chickens were carried 
out in duplicate trials. In each trial, 100 one-day-old Cobb-500 broiler chicks were obtained from 
Longenecker’s Hatchery Inc. (Elizabethtown, PA). Chick husbandry guidelines recommended by 
the Institutional Animal Care and Use Committee (IACUC, protocol number R-16-33) were 
followed. The chicks were provided with commercially available crumbles (Purina Animal 
Nutrition, MO) with no antibiotic supplementation. The chicks were assigned into 4 groups of 25 
chicks each in floor pens using a Completely Randomized Design consisting of a negative control, 
a positive control, and two treatment groups. The negative control group A was provided non-
supplemented tap water; the positive control group B was provided tap water supplemented with 
AGP (a combination of Oxytetracycline 1 µg/mL, Erythromycin 2 µg/mL, Tylosin 2 µg/mL, 
Bacitracin 4 µg/mL and Neomycin sulfate 32 µg/mL); the treatment group C was provided tap 
water supplemented with 0.1 g GAE/L of BPE; and treatment group D was provided tap water 





GAE/L during the last 72 h before euthanasia. The chicks were reared for 6 weeks and individual 
weights was recorded weekly. The data were analyzed with the Statistical Analysis System 
software (SAS, Institute Inc., Cary, NC, USA) using mixed effect Analysis of Variance (ANOVA) 
and Tukey’s modification for multiple mean comparisons.  
 
Sample collection and processing. After six weeks, all of the birds were euthanized with cervical 
dislocation followed by decapitation. Blood samples were collected in VACUETTE® Heparin 
Tubes (Greiner Bio-One, NC) and were analyzed with a ProCyte Dx® Hematology Analyzer 
(IDEXX, ME) according to the manufacturer’s instructions. Chicken organs, e.g., spleen, liver, 
heart, and pancreas, were collected and weighed immediately. Ceca lengths were measured and 
contents from both ceca were thoroughly mixed followed by storage at -80˚C until DNA extraction 
for metagenomic analysis. Contents from 5 ceca from each group to a total of 20 ceca were 
randomly selected for metagenomic analysis. DNA extraction was carried out with QIAamp Fast 
DNA Stool Mini Kit (QIAGEN, CA) according to the manufacturer’s instructions. Nextera DNA 
libraries were made for each of the 20 samples separately using Nextera DNA Library Preparation 
Kit and Nextera Index Kit (Illumina, San Diego, CA) followed by pooling into equimolar 
concentrations according to the manufacturer’s instructions. Paired-end sequencing (2 X 151 bp) 
was conducted on an Illumina NextSeq 500 sequencing platform with a NextSeq 500/550 v2 High 
Output flow cell.  
 
Analysis of metagenomics datasets. Data were demultiplexed using the BCL2FastQ program and 
PhiX reads were removed using DeconSeq (Schmieder and Edwards, 2011). Reads were further 
cleaned using Trimmomatic V 0.36 (leading 20, trailing 20, sliding 4:20, min len 36) (Bolger et 
al., 2014). Only paired data were further analyzed. After cleaning and curating the data the total 
reads in each sample ranged from 4.3×107 to 8.7×107 reads. Taxonomic labels were assigned to 
reads with taxonomic sequence classifier, Kraken, using Kraken-translate and --mpa format which 
reported levels of the taxonomy with standard rank assignments (Wood and Salzberg, 2014). The 
Kraken database was prepared using NCBI taxonomic information as well as the complete 
genomes in RefSeq for the bacterial, archaeal, and viral domains 
(https://www.ncbi.nlm.nih.gov/refseq/). Output files from Kraken were formatted with custom 





format which were ultimately fed into MEGAN (version 5.11.3, Huson et al., 2007) to generate 
matrices for sample comparisons. We determined relative abundances of microbial taxa in a cecum 
sample by dividing the number of reads of a specific taxon by the total number of reads in that 
sample. Initially the Bray-Curtis distance matrix and the Firmicutes/Bacteroidetes (F/B) ratio were 
determined for each sample in each treatment group (groups A, B, C, and D). Samples from a 
specific group that clustered together, contained cecal microbial profiles closest to the average of 
their respective groups, and possessed an F/B value ranging from 0.10 to 10.0 were considered to 
be the core microbiome representing that group and were used for further analysis (and we were 
left with a total of 12 samples, 3 from each group) (Mancabelli et al., 2016). Relative abundances 
from MEGAN-generated abundance matrices were used for statistical analysis, calculation of beta-
diversity, and alpha-diversity with genus richness, Shannon, and Fisher’s indexes. Rarefaction 
curves with genus richness, Shannon, and Fisher’s indexes were calculated using package vegan 
in R (version 3.3.1).  
For functional analysis, paired sequences were analyzed with metAMOS pipeline 
(Treangen et al., 2013). Output files from functional annotation section in metAMOS, which 
consisted UniProt ID of predicted proteins, were formatted with a custom scripts to generate 
assigned UniProt ID and abundances at tab delimited format. Retrieved UniProt entries were 
converted to the corresponding KEGG Orthology (KO) entries using Retrieve/ID mapping at 
http://www.uniprot.org/uploadlists/. A comparison matrix was prepared with Microsoft Query in 
Excel (version 2013) and fed to GraphPad Prism software (version 7) for statistical analysis. 
Interrogation of sequence reads for identity to known antibiotic resistance genes (ARGs) was 
performed using DIAMOND (Buchfink et al., 2015) (sequence identity > 90%, matched amino 
acid sequence length > 25, e-value < 10-5) and the database CARD (McArthur et al., 2013), which 
encompasses amino acid sequences of ARGs. 
 
Artificial development of resistance in C. jejuni against BPE. In this experiment, artificial 
development of resistance against BPE were monitored. Campylobacter jejuni RM1221 (ATCC 
BAA-1062TM) were used in the current study. The bacterium were grown in Blood agar (Himedia, 
India) with 5% defibrinated sheep blood (Ward’s Science) at 37˚C under microaerophilic (10% 
CO2, 5% O2, and 85% N2) condition. Bolton broth with 10% defibrinated blood to a final volume 





suspensions containing approximately 5×105 cfu/mL were added to each of the well of 24-wells 
plates. Plates were incubated for 48 hours at 37˚C under microaerophilic condition. Antibiotics 




Role of BPE on the expression of stress response genes of C. jejuni. 
A. RNA extraction and cDNA synthesis. The extraction of RNA were carried out according to the 
protocol of ZR Bacterial RNA MiniPrep kit (Zymo Research Corp., Irvine, CA). RNA 
quantification were carried out using a NanoDrop spectrophotometer (Thermo Scientific Inc., 
West Palm Beach, FL). The cDNA synthesis were performed according to the protocol of qScript 
cDNA SuperMix (Quanta Biosciences, Gaithersburg, MD). The eluted RNA (1 µg) were mixed 
with 4 µL of 5X qScript cDNA SuperMix containing optimized concentration of MgCl2, dNTPs, 
RNase inhibitor protein, qScript reverse transcriptase, random primers, oligo(dT) primer, and 






B. Quantitative RT-PCR assay. The mixture containing 10 µL of PerfeCTa SYBR Green FastMix, 
2 µL of each primer (100 nM), 2 µL of cDNA (10 ng), and 4 µL of RNase-free water were 
amplified using an Eco RT PCR system (Illumine, San Diego, CA), which were denatured at 95°C 
for 30 sec, followed by 40 cycles of 95°C for 5 sec, 55°C for 15 sec, and 72°C for 10 sec. The 
custom-synthesized oligonucleotides (Erofins MWG Operon; Huntsville, AL) were used as 
primers to target conserved regions of C. jejuni are listed in Table 5.1. The relative expression 
levels of genes were calculated by the comparative method (Livak, and Schmittgen, 2001). The 
CT values of target genes in treated C. jejuni cells were compared to the CT values obtained from 
the control. The housekeeping gene, 16S ribosomal RNA, were used as the reference gene for 




































Effect on chicken growth performance. Effect of supplemented diet on chicken growth promotion 
was measured at their 6 weeks of age (Fig. 5.1). Significant growth promotion (9.5% increase in 
mean body weight) was observed in chickens from group B who were provided with AGP  as 
water supplement compared to the group A  that were provided with only tap water (P = 0.001). 
Chickens from group C (provided with 0.1 g GAE/L of BPE) gained higher mean body weight by 
approximately 6% compared to group A (P = 0.029). No significant difference in weight gain was 
observed between group B and C (P = 0.242). Chickens from group D, where BPE concentration 
was increased to 1.0 g GAE/L during last 72 h before euthanasia, showed a mean body weight gain 
by more than 1% compared to group A (P = 0.488). However, when chickens were provided with 
1.0 g AGE/L BPE for consecutive 6 weeks, mean body weight was decreased by 4% compared to 
group A (data not shown) which suggested a concentration dependent mechanism of BPE on 
chicken growth performance. Organ weight to whole body weight ratio remained unaltered for 
spleen (P = 0.844), liver (P = 0.548), heart (P=0.560), and pancreas (0.599) among chickens from 
all 4 groups (Table 5.2). However, a concentration dependent increase in mean cecum length (by 
more than 12%) in chickens was observed when provided with BPE (P = 0.037). 
Hematologic analysis of five randomly selected chickens from each group showed no 
significant difference in tested parameters at alpha value of 0.05 (Table 5.3). Interesting to notice, 
mean RBC number of 2.8 million/µL in groups B and C compared to 2.5 million/µL in group A 
(P = 0.07). Similarly, 8.8 and 9.1 g/dL hemoglobin in groups B and C, respectively, compared to 
8.2 g/dL in group A (P = 0.07). Any behavioral alteration or differences in eating habits were not 
noticed among chickens from any group.    
 
Differential composition of gut microbiota. In order to assess the composition of gut microbiota in 
the 4 treatment groups, we analyzed cecal samples from 12 chickens (3 chickens from each group) 
with next-generation shotgun sequencing. The total number of reads in the cleaned and curated 
datasets from each sample ranged from 4.3×107 to 8.7×107.   
Evaluation of rarefaction curves based on microbial genus richness on sample datasets 
indicated that all 12 curves tend to form a plateau which bear evidence of adequate sequence 





curves did not reveal a noticeable difference among genus composition in the cecal contents from 
12 chickens. Shannon and Fisher’s diversity indexes calculated at the highest rarefaction depth 
covered in all the samples indicated no significant difference in diversity among the 4 groups at 
genus level. A Neighbor-Joining tree generated using the Bray-Curtis distance matrix indicated 
that there were similar microbial communities in groups B and C, whereas group D mainly 
clustered with group A, though statistical significance was not detected among these relationships 
(Fig. 5.2). One-way ANOVA on relative abundances of microbial domains revealed that group B 
possessed significantly higher number of DNA viruses compared to the other groups (P = 0.031) 
whereas no significant difference in the number of bacteria was observed among all the groups 
(Fig. 5.2). A numeric reduction in the mean relative abundance of bacteria was noticed in group B 
compared to the other groups (P = 0.661). Unpaired t-test analysis on relative abundance of archaea 
demonstrated significantly higher numbers in groups B and C compared to group A (P = 0.049 and 
0.031). Influence of archaeal communities in poultry gut is still an understudied area. Conversion 
of organic compounds to simple volatile fatty acids by fermentative bacteria leads to H2 
accumulation in the gut that inhibits the growth in animals. Methanogenic archaea in GI tract 
consume H2 and help to lower H2 partial pressure in gut (Saengkerdsub and Ricke, 2013).   
Assigned taxonomic profiles at the bacterial phylum level for pooled cecal samples 
revealed that Bacteroidetes was the dominant phylum (56.8%) in group A followed by Firmicutes 
(15%) and Proteobacteria (5%) (Fig. 3A). Relative abundances of bacterial phyla in individual 
samples are presented in supplementary file 3. In group A, relative abundances of Bacteroidetes, 
Firmicutes, and Proteobacteria ranged between 44.6 to 64.3%, 10.3 to 21.5%, and 5.0 to 9.1%, 
respectively (Supplementary file 3). In groups B and C, bacterial phyla distribution was dominated 
by Firmicutes (29.45 and 36.46%) followed by Bacteroidetes (23.62 and 31.11%) and 
Proteobacteria (21.29 and 7.55%). Differences in the community composition were observed 
among the different treatment groups. A higher relative abundance of Bacteroidetes in group A (P 
= 0.023) was detected, whereas a higher abundance of Firmicutes in groups B and C was observed 
compared to the other groups (P = 0.043). Group B possessed highest relative abundance of 
Proteobacteria, which was statistically significant at the alpha = 0.10 level. This finding was 
supported by Looft et al. (2012) who also reported that non-therapeutic concentration of 
chlortetracycline, sulfamethazine, and penicillin administered to piglets increased the prevalence 





as Escherichia, Campylobacter, Salmonella, Helicobacter, Pseudomonas, and many other notable 
pathogenic genera.  
Significant variation in the mean Firmicutes to Bacteroidetes (F/B) ratio (0.32, 1.32, 1.09, 
and 0.46 in groups A, B, C, and D, respectively) was noticed (P = 0.013). Pearson correlation 
coefficient indicated a moderately positive correlation between F/B ratio to chicken body weight 
(R2 = 0.483) (Fig. 5.3). This finding is supported by previous studies that showed increased F/B 
ratios were associated with AGP supplementation in feed and growth promotion in broilers (Singh 
et al., 2013; Mancabelli et al., 2016). In previous in vitro studies, we observed growth stimulation 
in Firmicutes, specifically probiotic Lactobacillus strains in the presence of berry extracts in broth, 
or chicken fecal medium that presented selective bias towards probiotic population when co-
cultured with pathogens (Yang et al., 2014; Salaheen et al., 2015). These findings indicate 
increased Firmicutes level in chicken ceca might be one of the many factors responsible for growth 
promotion in chickens with BPE supplementation.  
At the genus level a total of 670, 678, 691, and 683 bacterial taxa were identified in groups 
A, B, C, and D, respectively. As the reads were mapped to the lowest common ancestor (LCA) in 
this study, the identified number of genera in broiler cecum may not be comprehensive. Mancabelli 
et al., (2016) identified 252 taxa at genus level in broilers with 16s rRNA profiling. Sequencing 
methods, source of samples, and diet regimens may be responsible for variability in the number of 
bacterial genera in broilers. Significant differences at alpha value of 0.10 in the relative abundances 
of Bacteroides, Lactobacillus, Enterococcus, Escherichia, and Eubacterium genera were identified 
among treatment groups where relative abundance of Bacteroides was the highest in group A; 
Enterococcus and Escherichia in group B; and Lactobacillus and Eubacterium in group C (Fig. 
5.3). Oakley and Kogut (2016) also reported significantly higher abundance of Bacteroides in ceca 
of broilers grown without AGP. Whereas, Viveros et al., (2011) reported higher abundance of 
Lactobacillus in broilers provided with plant extracts. Observed differences in the composition of 
bacterial genera may influence the dynamics of feed to energy conversion in chickens from 
different treatment groups.  
There were no significant differences in the relative abundances of DNA viruses in the 
samples. However, based on presence or absence of a virus in a sample, bacteriophages e.g., Mu-
like viruses, N15-like viruses, Phikz-like viruses, T7-like viruses, and Inoviruses were more 





the mean abundances of Lamda-like viruses, Mardiviruses, and T4-like viruses was noticed in 
group B. Metagenomic studies in swine and mice model reported phage induction in gut due to 
oral supplementation with antibiotics (Allen et al., 2011; Modi et al., 2013). A collateral 
consequence of phage induction is gene transfer that promote both pathogen evolution and transfer 
of antibiotic resistance genes (Allen and Stanton, 2014).     
 
Functional classification of chicken cecal microbiome. Assessment of the functional classification 
of open reading frames based on the KEGG Orthology (KO) database obtained from metagenomic 
datasets revealed significant variation in functional orthologs among the groups (Fig. 5.4). 
Analysis was directed towards enzymes that involved in carbohydrate metabolism and energy 
production and further sorted to enzymes showing variation among different datasets. Significant 
variations were observed in the relative abundance of several enzymes. Phosphoenolpyruvate 
carboxykinase, formate dehydrogenase major subunit, and 2-oxoglutarate dehydrogenase E1 
component (involved in carbon metabolism,  glyoxylate and dicarboxylate metabolism, methane 
metabolism, tryptophan metabolism, and lysine degradation) were more abundant in group C than 
in the other groups (P < 0.10). Whereas, L-xylulokinase, α-glucosidase, and tartronate-
semialdehyde synthase (involved in pentose and glucuronate interconversions, ascorbate, aldarate, 
starch, sucrose, glyoxylate, and dicarboxylate metabolism) were highly abundant in group B (P < 
0.10). Chicken cecal microbiome from group D possessed higher relative abundance of F-type H+-
transporting ATPase subunit beta, and glycerol kinase (P < 0.10). These observations indicate 
metabolic diversions in chickens that were provided with AGPs or BPE, though both of these 
treatments resulted in higher body weight in chickens. These differences can be explained by the 
variability in the microbial communities, especially, Bacteroidetes and Firmicutes, that harbor 
important enzymes (e.g., pectinase, and cellulase) to hydrolyze cell wall components from plant 
based diets (Thomas et al., 2011).   
 
Prediction of the cecal resistome profile. The core The core resistome of the microbial consortia 
residing in chicken cecal contents collected from various groups were generated by screening for 
known bacterial antibiotic resistance genes (ARGs) followed by sorting the genes based on their 
relative abundances (at-least one read per 10 million sequences) in the cecal samples. In silico 





compared to group A (P = 0.067) (Fig. 5.5). Core resistomes of groups A, B, C, and D consisted 
69, 103, 88, and 69 ARGs (from 3286, 5870, 3685, and 3081 reads per 10 million sequences), 
respectively. Both transferable ARGs and efflux pump mediatory ARGs were present in these core 
resistomes. Core resistomes of the treatment groups were generated this way: 112, 79, and 103 
ARGs in group A; 129, 124, and 121 ARGs in group B; 108, 102, and 115 ARGs in group C; and 
finally 94, 111, and 80 ARGs in group D. Based on gene functions, the identified ARGs in 
individual samples were further assigned to 14 groups: resistance to aminocoumarin, 
aminoglycosides, beta-lactam, sulfonamides, bacitracin, chloramphenicol, fluoroquinolone 
(transferable element based), glycopeptide antibiotics, trimethoprim, macrolide-lincosamide-
streptogramin B, polymyxin, streptothricin, tetracyclines, and efflux pump conferring resistance. 
Chloramphenicol acetyltransferase (cat) and CcrA beta-lactamase genes were found in all the 
samples but due to assigned abundance threshold, i.e., at-least one read per 10 million sequences, 
these genes were not listed in core resistome of group B. Higher relative abundance of beta-
lactamases were previously reported in broilers grown with AGPs but absence of beta-lactam 
antibiotics in the AGP-mixture that was used in this study may be responsible for lower abundance 
of beta-lactamases (Laube et al., 2013; Mancabelli et al., 2016). Two out of 3 samples from group 
B contained trimethoprim resistance gene, dfrA1, hence missed from the group B resistome but no 
trimethoprim resistance gene was identified in other groups. Sulfonamide resistant dihydropteroate 
synthase genes (sul1 and sul2) were only observed in all the samples from group B but not in other 
groups. sul1 and sul2 are commonly associated with mobile genetic elements and predominance 
of resistant enteric bacteria associated with these genes has been reported in broilers grown with 
AGPs (Diarra et al., 2007; Simmons et al., 2016). In this study, percentages of ARGs associated 
with efflux pump mediated antibiotic resistance in core resistomes of groups A, B, C, and D were 
39.1, 49.5, 46.6, and 39.1, respectively.  
A total of 52 ARGs from 10 out of 14 ARG groups showed coexistence in all of the core 
resistomes. Relative abundances of aminoglycoside, bacitracin, fluoroquinolone (transferable 
elements), polymyxin, streptothricin, tetracycline and efflux pump conferring antibiotic resistance 
genes were higher in group B compared to the other groups (P < 0.05) (Fig. 5.5). Relative 
abundances of macrolide-lincosamaide-streptogramin resistance genes were also significantly 
higher in group B at alpha value of 0.10. No significant variation in the relative abundances of 





incorporation of bacitracin (glycopeptide), erythromycin (macrolide), neomycin sulfate 
(aminoglycoside), oxytetracycline (tetracycline), and tylosin (macrolide), supplementation in 
chickens from group B is associated with higher relative abundances of ARGs in the cecal 
resistome. These findings are supported by previous studies that reported the association between 
the use of antibiotics in feed with development of ARGs in complex ecosystems (Andersson and 
Hughes, 2014; Levy 2014; Roca et al., 2015). 
Based on the best-hit results from the DIAMOND analysis using the CARD database, the 
majority of identified ARGs were highly similar to those previously identified in  Actinobacteria, 
Bacteroidetes, Firmicutes, and Proteobacteria (Fig. 5.5). Among the ARGs similar to those 
identified in Actinobacteria, 42 to 54% were more specifically similar to those previously 
identified in the Bifidobacteriales order. Significantly lower ARGs associated with Bacteroidetes 
were identified in group B (0.14%) compared to groups A, C, and D (19.03, 11.01, and 15.64%, 
respectively) which can be explained by reduced relative abundance of Bacteroidetes in cecal 
microbiome of group B. Mancabelli et al., (2016) also observed high abundance of Bacteroidetes-
associated ARGs in cecal resistomes of chickens grown without antibiotic supplementation. 
Alternatively, higher relative abundances of ARGs associated with Proteobacteria were observed 
in group B (41.93%) compared to the other groups. Higher relative abundances of Proteobacteria 
in chichen cecal microbiomes from group B were likely responsible for higher Proteobacteria-
associated ARGs (Danzeisen et al., 2011).   
 
Can C. jejuni become resistant towards BPE? In this study, with consecutive increase of antibiotic 
Kanamycin concentration in the growth medium, we developed C. jejuni strain possessing MIC 
value of > 100 µg/mL towards kanamycin. Consecutive increase of BPE concentration in the 
growth medium resulted in increased MIC to 0.9 mg GAE/mL from pre-documented MIC value 
of 0.3 mg GAE/mL. However, subculturing the BPE resistant C. jejuni in BPE-free medium 
resulted in revival of the original MIC of 0.3 mg GAE/mL. 
Expression of strss response genes in C. jejuni with qRT-PCR showed significant 
downregulation of peroxide-sensing regulator (perB), Flavodoxin I (fldA), Superoxide dismutase 
(sodB), Alkyl hydroperoxide reductase (ahpC), Nonheme iron-containing ferritin (cft), Ferredoxin 
(fdxA), Ferric uptake regulator (fur), Bacterioferritin comigratory protein homolog (BCP), Rod 











Modulation of gut microbiota with antibiotic growth promoters (AGP) for enhanced performance 
in poultry can be justified until acquisition of antibiotic resistance in zoonotic bacterial pathogens 
through inter-bacterial transfer of antibiotic resistance genes (ARGs) in a complex microbial 
community is considered. In this study, we adopted mass-spec, phylogenetic, and metagenomice 
approaches to evaluate bioactive phenolic extracts (BPE) from blueberry (Vaccinium 
corymbosum) and blackberry (Rubus fruticosus) pomaces as alternative performance enhancer in 
poultry. We raised a total of 300 Cobb-500 broiler chicks receiving water W/ or W/O AGP (tylosin, 
neomycin sulfate, bacitracin, erythromycin, and oxytetracycline), or BPE supplementation for six 
weeks and discovered more than 6% increase in mean chicken weight gain with BPE 
supplementation compared to 9.5% with AGP. BPE caused an AGP-like pattern in bacterial 
community with comparative increase of Firmicutes and a concomitant reduction of Bacteroidetes 
in chicken ceca. This finding is supported by previous literature that showed increased F/B ratio 
in correlation with AGP supplementation in feed and growth promotion in broilers (Singh et al., 
2013; Mancabelli et al., 2016). In previous in vitro studies, we observed growth stimulation in 
Firmicutes, specifically probiotic Lactobacillus strains in the presence of berry extracts in broth, 
or chicken fecal medium that presented selective bias towards probiotic population when co-
cultured with pathogens (Yang et al., 2014; Salaheen et al., 2015). These findings indicate 
increased Firmicutes level in chicken ceca might be one of the many factors behind growth 
promotion in chickens with BPE supplementation. 
AGP supplementation clearly caused phage induction and a richer resistome profile in 
cecal microbiome compared to BPE or regular tap water. Incorporation of bacitracin, 
erythromycin, neomycin sulfate, oxytetracycline, and tylosin, as water supplement in chickens 
from this group can be considered responsible for the phenomenon. Metagenomic studies in swine 
and mice model reported phage induction in gut due to oral supplementation with antibiotics (Allen 





promote both pathogen evolution and transfer of antibiotic resistance genes (Allen and Stanton, 
2014). Both AGP and BPE supplementation resulted in elevated relative abundance of archaea. 
Methanogenic archaea in GI tract consume H2 and help to lower H2 partial pressure in gut 































1. BPE supplementation in water increased the mean body weight of chickens by 6%. 
2. BPE caused an AGP-like pattern in bacterial community with comparative increase of 
Firmicutes and a concomitant reduction of Bacteroidetes in chicken ceca.  
3. AGP resulted higher prevalence of bacteriophages in the cecal microbiome compared to 
BPE. 
4. BPE and AGP resulted in cecal microbiome with over-represented functional orthologs 
involved in carbon fixation in photosynthetic bacteria, carbon and amino acid metabolism, 
starch and cellulose metabolism, oxidative phosphorylation, and lipid metabolism.  
5. Analysis of resistome profile of cecal microbiomes revealed higher predicted ARGs in 
chickens provided with AGP compared to BPE. 
6. Sequential increase of BPE in growth medium doubled the MIC of BPE to C. jejuni but 
the strain became susceptible to BPE just after one subculte in BPE-free medium. 

























List of Figures and Tables 
Table 5.1. List of primers for stress response gene expression of C. jejuni 
Function/protein Gene Primer Sequences (5’-3’) References 
Peroxide-sensing 
regulator 
perR Forward TTCAATCTCTTTAGCGACGG Xie et al., 20
11 Reverse CACATTTGGCGCAAACAACA 
Flavodoxin I fldA Forward TCCACCAAGACTAAGCCCTG Xie et al., 
2011 Reverse CAGAAGGAGCGGCTAATACAA 
Iron-binding 
protein 
dps Forward CCACTAATGTTAATATGCGTTCC Xie et al., 
2011 Reverse TGTGCTTGATAATCTTGCGACAA 
Superoxide 
dismutase (Fe) 
sodB Forward TGGCGGTTCATGTCAAAGTA Xie et al., 




ahpC Forward AGTTGCCCTTCGTGGTTCGT Xie et al., 
2011 Reverse ATCGCCCTTATTCCATCCTG 
Catalase katA Forward ACCGTTCATGCTAAGGGAAG Xie et al., 
2011 Reverse CCTACCAAGTCCCAGTTTCC 
Nonheme iron-
containing ferritin 
cft Forward TTCTTCTTCGTGTTGTTCGC Xie et al., 
2011 Reverse GCTGGAGCCTTCTTGTTTGC 
Ferredoxin fdxA Forward CCCCACTTCTCATATCAGCG Xie et al., 
2011 Reverse ATGCGTTGAATGCGTAGGAC 
Rubrerythrin rbr Forward TGCAGCAGTTACTAGGTTTT Xie et al., 
2011 Reverse AGACATTTTAGAGAAGCGGC 
Ferric uptake 
regulator 
fur Forward CCATTTCTTTTGGTTCAGCAG Xie et al., 
2011 Reverse TGCAATCAAGGCTTGCTGTC 
Carbon storage 
regulator 
csrA Forward TCAAAGTCGTTCAAACAGGG Xie et al., 
2011 Reverse TCATTCTGAACAACAGAATGC 
Probable thiol 
peroxidase 
tpx Forward GCCAGTTACAATGGTGCTGA Xie et al., 
2011 Reverse TTTGCCACAAAATCACTTGC 
Cochaperonin groES Forward AAACAACAGCCTCAGGCATAA Xie et al., 
2011 Reverse TTCTGTTCCACCGTATTTAGCA 
Chaperonin groEL Forward GCAGGCGATGGAACAACTAC Xie et al., 
2011 Reverse TCCATACCGCGTTTTACCTC 
Chaperone dnaK Forward CGGTATGCCACAAATCGAAG Xie et al., 
2011 Reverse GCTAAGTCCGCTTGAACCTG 
Cochaperone dnaJ Forward TTTAAAAGGCGGTGGATTTG Xie et al., 




BCP Forward ACCCCAGGTTGTACTACAGAAG Xie et al., 
2011 Reverse AGCAATCTTACCTGTTTCATCG 
RelA/Spot family 
protein 
spoT Forward GCCCCAATAGCCCATAGAC Xie et al., 




mreB Forward GAGCCTTCTGTTGTGGCAGTT Xie et al., 




cmeA Forward TATTACGCCGCTAACTTGAG Xie et al., 





cmeB Forward TAATCCAGGTATGGGAGGTA Xie et al., 









cmeC Forward GGACGTTGAAGCAAGATGGT Xie et al., 
2011 Reverse AGTTGGCGCTGTAGGTGAAT 
Major outer 
membrane protein 
porA Forward TTGATAGCGAACTTGATGAT Xie et al., 
2011 Reverse ATACGAAGTCAGCACCAACG 
Inner membrane 
protein 
yagU Forward CTATTTCCATACCCCACAGC Xie et al., 




clpA Forward GTAGGAGCTGGAAGCACAGG Xie et al., 





























Table 5.2. Relative organ to body weights and cecum length of broilers at day 42. 
Organs A B C D p-value 
Spleen1 0.13a 0.12a 0.12a 0.13a 0.844 
Liver1 2.18a  2.22a 2.07a 2.08a 0.548 
Heart1  0.53a 0.53a 0.50a 0.53a 0.56 
Pancrease1 0.86a 0.79a 0.79a 0.79a 0.599 
Cecum2 17.24a 18.64a 19.15b 19.43b 0.037 
1Ratio: Organ weight to total body weight during euthanasia; 
2Length (cm) 

























Table 5.3. Effect of BPE compared to AGPs on blood parameters and indices of broilers at day 
42. 
Blood parameters A B C D p-value 
RBC (×106/µL) 2.5±0.21 2.8±0.2 2.8±0.1 2.7±0.1 0.07 
WBC (×103/ µL) 551.5±212.6 644.2±159.2 565.7±100.3 774.6±87.3 0.11 
Neutrophil (×103/ µL) 532.4±206.9 617.8±150.5 544.7±93.7 744.4±71.3 0.11 
Lymphocyte (×103/ µL) 13.5±2.6 17.5±6.7 15.4±6.1 17.8±5.4 0.58 
Monocyte (×103/ µL) 0.4±0.4 0.5±0.3 0.7±0.4 0.8±1.5 0.85 
Eosinophil (×103/ µL) 2.5±3.2 5.8±5.8 3.7±5.3 8.6±13.5 0.64 
Basophil (×103/ µL) 2.7±1.7 2.7±1.5 1.3±0.5 3.0±1.0 0.16 
Hemoglobin (g/100mL) 8.2±0.5 8.8±0.6 9.1±0.4 8.8±0.3 0.07 
Hematocrit (%) 29.4±2.1 30.8±1.7 31.4±1.5 30.7±0.9 0.26 























Fig. 5.1. Effect of berry pomace extracts compared to AGPs on the performance of broilers at 
day 42. Groups were assigned in the following manner; broilers from group A (negative control): 
only tap water, group B (positive control): tap water with AGP, group C: tap water with 0.1 g 
GAE/L of BPE, and group D: tap water with 0.1 g GAE/L of BPE for 39 days and 1.0 g GAE/L 
of BPE for last 3 days before euthanasia. * indicates significant variation compared to the 





















Fig. 5.2. Assessment of alpha-diversity in samples from the control and treatment groups. Panel 
A displays the rarefaction curve indicating genus richness at increasing sequencing depth of 
sample from groups A, B, C, and D. Panel B exhibits Neighbor-Joining tree based on Bray-
Curtis distance matrix encompassing 12 datasets from all the groups. Panel C shows relative 
abundances of various taxa at super kingdom level in various groups. * indicates significant 
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Fig. 5.3.  Differential composition of chicken ceca microbiota. Panel A depicts bacterial 
distribution at phylum level in 3D plot with pooled datasets. Panel B demonstrates a scatter plot 
of Firmicutes to Bacteoirdetes (F/B) ratio to broiler weight at 42 days of age. Panel C shows 
bacterial distribution at genus level in all the broiler groups.  Finally, panel D displays the 
variation in the presence or absence of DNA viruses at genus level in samples from groups A, B, 
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Fig. 5.4. Functional classification of chicken cecal microbiomes from groups A, B, C, and D. 
Relative abundances were calculated based on the numbers for every 100 million sequences.  * 
and ** indicates significant difference in relative abundance of a KO functional orthog at alpha 

























































































































































































































































Fig. 5.5. Evaluation of resistome profiles in chicken gut microbiome. Panel A shows relative 
abundance (reads per 10 million sequences) of total Antibiotic Resistance Genes (ARGs) 
observed in core resistomes of broiler ceca from groups A, B, C, and D. Panel B depicts percent 
contribution of microbial taxa on  relative abundances of ARGs in the core resistomes. Panel C 
exhibits a heatmap encompassing relative abundances of shared ARGs among the treatment 
groups in logarithmic scale. 































































































A B C D
A m ino c o um a rin re s is ta nc e
A m ino glyc o s id e  re s is ta nc e * *
B a c itra c in re s is ta nc e * *
E fflux p um p  c o nfe ring re s is ta nc e * *
F luo ro q uino lo ne  re s is ta nc e * *
G lyc o p e p tid e  a ntib io tic s  re s is ta nc e
M a c ro lid e - L inc o sa m id e - S tre p to gra m inB  re s is ta nc e *
P o lym yxin re s is ta nc e * *
S tre p to thric in re s is ta nc e * *


































































































































1. Berry pomaces are rich sources of bioactive phenolics. HPLC-MS analysis 
indicated that both blueberry and blackaberry pomace extracts contained thousands 
of compounds. 
2. BPE inhibited C. jejuni growth in vitro, altered its pathogenicity, and 
physicochemical properties, as well as, its interactions with cultured host cells ex-
vivo.  
3. BPE inhibited the growth of commercially important poultry pathogens, e.g., P. 
multocida, S. Gallinarum, and S. Pullorum in vitro. BPE supported probiotic L. 
plantarum to competitively inhibit the growth of pathogenic S. Gallinarum, and S. 
Pullorum in a co-culture model.  
4. 1.0 g GAE/L of BPE as water supplement reduced natural colonization of 
Campylobacter in broiler ceca by 5 logs at 6 weeks of age in floor pens, whereas 
1.0 g GAE/L of BPE as water supplement for 72 h before euthanasia resulted 
approximately 2 logs reduced natural colonization of Campylobacter in chicken 
ceca at 6 weeks of age in floor pens.  
5. 1.0 g GAE/L of BPE reduced marked C. jejuni colonization by 1 log upto 3 weeks 
of age while grown in isolated cageing system. 
6. BPE supplementation in water increased the mean body weight of chickens by 6% 
compared to 9.5% with AGP supplementation. 
7. BPE caused an AGP-like pattern in bacterial community with comparative increase 
of Firmicutes and a concomitant reduction of Bacteroidetes in chicken ceca. 
However, AGP was associated with increased relative abundance of Proteobacteria.  
8. AGP resulted higher prevalence of bacteriophages in the cecal microbiome 
compared to BPE. 
9. BPE and AGP resulted in cecal microbiome with over-represented functional 
orthologs involved in carbohydrate and energy metabolism.  
10. Analysis of resistome profile of cecal microbiomes revealed higher predicted ARGs 
in chickens provided with AGP compared to BPE. 
11. Sequential increase of BPE in growth medium doubled the MIC of BPE to C. jejuni 
but the strain became susceptible to BPE just after one subculte in BPE-free 
medium. 








1. Supplementation of metagenomic data with metabolomic and    metatranscriptiomic 
datasets. 
2. Large scale growth promotion study at farm level. 




























Probiotics Microorganism that are introduced into the body for beneficial 
purposes. 
Metagenome The total extractable DNA from an environment. The chicken 
cecal metagenome is the collection of the DNA of the chicken 
and the cecal microbiota. Metagenome is often referred to as 
microbiome. 
Metagenomics The study of the metagenome or microbiome. Metagenomics 
can be targeted study with 16S ribosomal RNA or shotgun 
sequencing based untargeted study. 
Microbiota The collective microbial (bacteria, virus, archaea) community 
that inhabit a specific environment, e.g., chicken cecal 
microbiota or human skin microbiota.  
Microbiome The collective microbial genomic contents. It also provides 
information on the the total genetic capacity of the microbial 
community. 
Resistome The collection of antibiotic resistance genes in a microbiome.  
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